Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
Dec. 28, 2013 | Mar. 24, 2014 | Jun. 29, 2013 | |
Document Type | '10-K | ' | ' |
Amendment Flag | 'false | ' | ' |
Document Period End Date | 28-Dec-13 | ' | ' |
Trading Symbol | 'crlrf | ' | ' |
Entity Registrant Name | 'CRAILAR TECHNOLOGIES INC | ' | ' |
Entity Central Index Key | '0001210294 | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Filer Category | 'Accelerated Filer | ' | ' |
Entity Common Stock, Shares Outstanding | ' | 50,679,097 | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Well Known Seasoned Issuer | 'No | ' | ' |
Entity Public Float | ' | ' | $44,399,388 |
Document Fiscal Year Focus | '2013 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Current | ' | ' |
Cash and cash equivalents | $1,193,365 | $2,877,210 |
Receivables | 223,105 | 72,292 |
Inventory | 945,040 | 2,904,652 |
Prepaid expenses and deposits | 290,872 | 106,785 |
Total Current Assets | 2,652,382 | 5,960,939 |
Deferred Debt Issuance Costs | 1,442,023 | 1,024,294 |
Property and Equipment, net | 17,240,012 | 13,248,688 |
Intangible Assets, net | 155,545 | 94,619 |
Total Assets | 21,489,962 | 20,328,540 |
Current | ' | ' |
Accounts payable | 2,377,901 | 1,406,418 |
Accrued liabilities | 2,342,153 | 1,480,624 |
Unearned revenue | 247,655 | 0 |
Notes payable | 476,614 | 0 |
Current portion of loans | 634,486 | 0 |
Derivative liabilities | 0 | 488,035 |
Total Current Liabilities | 6,078,809 | 3,375,077 |
Deferred Income Tax Liability | 199,131 | 0 |
Loans Payable | 551,190 | 0 |
Long Term Debt | 16,674,686 | 10,051,262 |
Total Liabilities | 23,503,816 | 13,426,339 |
STOCKHOLDERS' EQUITY (DEFICIT) | ' | ' |
Capital Stock Authorized: 100,000,000 common shares without par value Issued and outstanding : 47,806,031 common shares (December 31, 2012 - 44,239,198) | 34,889,370 | 32,616,795 |
Subscription receivable | 0 | -64,050 |
Additional Paid-in Capital | 9,934,322 | 7,061,406 |
Accumulated Other Comprehensive Income (Loss) | 585,301 | -459,036 |
Deficit | -11,485,251 | -11,485,251 |
Deficit accumulated in the development stage | -35,937,596 | -20,767,663 |
Total Stockholders Equity | -2,013,854 | 6,902,201 |
Total Liabilities and Stockholders Equity | $21,489,962 | $20,328,540 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
Common Stock, No Par Value | ' | ' |
Common Stock, Shares, Issued | 47,806,031 | 44,239,198 |
Common Stock, Shares, Outstanding | 47,806,031 | 44,239,198 |
Consolidated_Statements_of_Ope
Consolidated Statements of Operations (USD $) | 12 Months Ended | 51 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | |
Revenues | $587,225 | $0 | $587,225 |
Cost of sales | ' | ' | ' |
Materials and direct production costs | 470,115 | 0 | 470,115 |
Facility commissioning costs | 1,896,822 | 0 | 1,896,822 |
Depreciation | 680,839 | 0 | 680,839 |
Impairment loss on inventory | 4,642,262 | 0 | 4,642,262 |
Total Cost of sales | 7,690,038 | 0 | 7,690,038 |
Gross loss | -7,102,813 | 0 | -7,102,813 |
Expenses | ' | ' | ' |
Marketing and promotion | 663,438 | 672,305 | 1,594,475 |
Amortization and depreciation | 174,555 | 278,805 | 560,418 |
General and administrative | 5,681,467 | 6,608,524 | 20,936,061 |
Total Expenses | 6,519,459 | 7,559,634 | 23,090,953 |
Loss before other items | -13,622,272 | -7,559,634 | -30,193,766 |
Other income (expense): | ' | ' | ' |
Research and development | -355,099 | -660,229 | -2,595,116 |
Gain on disposal of assets | 790 | 0 | 790 |
Interest | -2,058,738 | -99,655 | -2,455,400 |
Write off of equipment | -13,368 | -593,894 | -704,516 |
Impairment loss on inventory | 0 | -303,663 | -303,663 |
Fair value adjustment derivative liabilities | 452,845 | -98,285 | -113,011 |
Bargain purchase | 425,909 | 0 | 425,909 |
Other | 0 | 0 | 1,177 |
Total Other income (expense) | -1,547,661 | -1,755,726 | -5,743,830 |
Net loss | -15,169,933 | -9,315,360 | -35,937,596 |
Other comprehensive income (loss) | ' | ' | ' |
Exchange differences on translating to presentation currency | 1,044,337 | -35,685 | ' |
Comprehensive loss | ($14,125,596) | ($9,351,045) | ' |
Loss per share (basic and diluted) | ($0.34) | ($0.22) | ' |
Weighted average number of common shares outstanding | 44,508,011 | 43,009,226 | ' |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 12 Months Ended | 51 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | |
Cash flows used in operating activities | ' | ' | ' |
Net loss | ($15,169,933) | ($9,315,360) | ($35,937,596) |
Adjustments to reconcile net loss to net cash from operating activities | ' | ' | ' |
Accretion expense | 127,525 | 0 | 127,525 |
Amortization and depreciation | 855,394 | 278,805 | 1,241,257 |
Amortization of deferred debt issuance costs | 346,789 | 90,220 | 437,009 |
Fair value adjustment of derivative liability | -452,845 | 98,285 | 113,011 |
Gain on disposal of assets | -790 | 0 | -790 |
Rent | 151,539 | 119,836 | 271,375 |
Stock-based compensation | 2,004,647 | 2,397,819 | 8,142,956 |
Write off of equipment | 13,368 | 593,894 | 704,516 |
Impairment of inventory | 4,642,262 | 303,663 | 4,945,925 |
Bargain purchase | 425,909 | 0 | 425,909 |
Gain on foreign exchange | 0 | 0 | -71,990 |
Changes in working capital assets and liabilities | ' | ' | ' |
Decrease (increase) in accounts receivable | -86,763 | 78,622 | -82,108 |
Increase in inventory | -2,682,650 | -2,172,349 | -5,890,965 |
Increase in prepaid expenses | -184,087 | -59,538 | -220,747 |
Increase in accounts payable | 971,483 | 1,170,703 | 2,108,705 |
Increase in unearned revenue | 247,655 | 0 | 247,655 |
Increase in accrued liabilities | 709,990 | 521,769 | 1,454,498 |
Increase in loans payable | 0 | 0 | 56,945 |
Net cash used in operating activities | -8,080,507 | -5,893,631 | -21,926,910 |
Cash flows used in investing activities | ' | ' | ' |
Sale of equipment | 35,790 | 0 | 35,790 |
Acquisition of property and equipment | -3,907,808 | -10,419,945 | -17,547,230 |
Acquisition of intangible assets | -89,306 | -30,268 | -194,175 |
Net cash flows used in investing activities | -3,961,324 | -10,450,213 | -17,705,615 |
Cash flows from financing activities | ' | ' | ' |
Issuance of capital stock and warrants | 239,746 | 3,948,908 | 22,203,727 |
Net proceeds from promissory notes | 621,009 | 0 | 421,009 |
Proceeds from private placement | 1,879,400 | 0 | 1,879,400 |
Proceeds from convertible debenture | 8,307,249 | 10,051,262 | 18,358,511 |
Deferred issuance costs | -886,733 | -1,083,936 | -1,970,669 |
Related parties payments | 0 | 0 | -1,025,960 |
Net cash flows from financing activities | 10,160,671 | 12,916,234 | 39,866,018 |
Effect of exchange rate changes on cash and cash equivalents | 197,315 | -35,685 | -93,575 |
Increase (decrease) in cash and cash equivalents | -1,683,845 | -3,463,295 | 139,918 |
Cash and cash equivalents, beginning | 2,877,210 | 6,340,505 | 1,053,447 |
Cash and cash equivalents, ending | 1,193,365 | 2,877,210 | 1,193,365 |
SUPPLEMENTAL CASH FLOW INFORMATION AND NON-CASH FINANCING AND INVESTING ACTIVITIES: | ' | ' | ' |
Cash paid for interest | 1,347,905 | 9,435 | 0 |
Cash paid for income taxes | $0 | $0 | $0 |
Statement_of_Stockholders_Equi
Statement of Stockholders Equity (USD $) | Common shares [Member] | Additional paid-in capital [Member] | Subscription Receivable [Member] | Accumulated other comprehensive income \ (loss) [Member] | Deficit [Member] | Deficit (Development stage) [Member] | Total |
Beginning Balance at Dec. 31, 2009 | $9,422,178 | $2,011,047 | ' | ($12,840) | ($11,485,251) | ($1,159,942) | ($1,224,808) |
Beginning Balance (Shares) at Dec. 31, 2009 | 33,354,215 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 12, 2010 for exercise of options at $0.80 per share | 2,960 | ' | ' | ' | ' | ' | 2,960 |
Issuance of common stock on January 12, 2010 for exercise of options at $0.80 per share (Shares) | 3,700 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 27, 2010 for exercise of options at $0.80 per share | 2,240 | ' | ' | ' | ' | ' | 2,240 |
Issuance of common stock on January 27, 2010 for exercise of options at $0.80 per share (Shares) | 2,800 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 4, 2010 for exercise of options at $0.80 per share | 5,040 | ' | ' | ' | ' | ' | 5,040 |
Issuance of common stock on February 4, 2010 for exercise of options at $0.80 per share (Shares) | 6,300 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 23, 2010 for exercise of options at $0.80 per share | 2,460 | ' | ' | ' | ' | ' | 2,460 |
Issuance of common stock on February 23, 2010 for exercise of options at $0.80 per share (Shares) | 3,075 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 5, 2010 for exercise of options at $0.37 per share | 9,250 | ' | ' | ' | ' | ' | 9,250 |
Issuance of common stock on March 5, 2010 for exercise of options at $0.37 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 11, 2010 for exercise of options at $0.50 per share | 5,000 | ' | ' | ' | ' | ' | 5,000 |
Issuance of common stock on March 11, 2010 for exercise of options at $0.50 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 15, 2010 for exercise of options at $0.50 per share | 5,000 | ' | ' | ' | ' | ' | 5,000 |
Issuance of common stock on March 15, 2010 for exercise of options at $0.50 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share | 10,000 | ' | ' | ' | ' | ' | 10,000 |
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (second) | 5,000 | ' | ' | ' | ' | ' | 5,000 |
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (second) (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (third) | 5,000 | ' | ' | ' | ' | ' | 5,000 |
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (third) (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 29, 2010 for exercise of options at $0.80 per share | 1,400 | ' | ' | ' | ' | ' | 1,400 |
Issuance of common stock on March 29, 2010 for exercise of options at $0.80 per share (Shares) | 1,750 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 13, 2010 for exercise of options at $0.80 per share | 20,000 | ' | ' | ' | ' | ' | 20,000 |
Issuance of common stock on April 13, 2010 for exercise of options at $0.80 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 29, 2010 for exercise of options at $0.50 per share | 24,000 | ' | ' | ' | ' | ' | 24,000 |
Issuance of common stock on April 29, 2010 for exercise of options at $0.50 per share (Shares) | 48,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 5, 2010 for exercise of options at $0.50 per share | 12,000 | ' | ' | ' | ' | ' | 12,000 |
Issuance of common stock on May 5, 2010 for exercise of options at $0.50 per share (Shares) | 24,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 7, 2010 for exercise of options at $0.50 per share | 34,000 | ' | ' | ' | ' | ' | 34,000 |
Issuance of common stock on May 7, 2010 for exercise of options at $0.50 per share (Shares) | 68,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 13, 2010 for exercise of options at $0.50 per share | 25,000 | ' | ' | ' | ' | ' | 25,000 |
Issuance of common stock on May 13, 2010 for exercise of options at $0.50 per share (Shares) | 50,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 14, 2010 for exercise of options at $0.50 per share | 60,000 | ' | ' | ' | ' | ' | 60,000 |
Issuance of common stock on May 14, 2010 for exercise of options at $0.50 per share (Shares) | 120,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 19, 2010 for cash - $1.00, net of share issue costs | 1,362,587 | ' | ' | ' | ' | ' | 1,362,587 |
Issuance of common stock on May 19, 2010 for cash - $1.00, net of share issue costs (Shares) | 1,424,739 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share | 20,000 | ' | ' | ' | ' | ' | 20,000 |
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share (second) | 10,000 | ' | ' | ' | ' | ' | 10,000 |
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share (second) (Shares) | 12,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share | 13,649 | ' | ' | ' | ' | ' | 13,649 |
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share (Shares) | 17,061 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share (second) | 13,650 | ' | ' | ' | ' | ' | 13,650 |
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share (second) (Shares) | 17,062 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on August 4, 2010 for exercise of options at $0.80 per share | 20,000 | ' | ' | ' | ' | ' | 20,000 |
Issuance of common stock on August 4, 2010 for exercise of options at $0.80 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Transfer addition paid-in capital for options exercised in the year | 171,289 | -171,289 | ' | ' | ' | ' | ' |
Set up derivative liabilities for warrants granted in the year | -482,960 | ' | ' | ' | ' | ' | -482,960 |
Stock-based compensation | ' | 930,644 | ' | ' | ' | ' | 930,644 |
Foreign currency translation | ' | ' | ' | -112,314 | ' | ' | -112,314 |
Net loss | ' | ' | ' | ' | ' | -3,293,439 | -3,293,439 |
Ending Balance at Dec. 31, 2010 | 10,778,742 | 2,770,402 | ' | -125,154 | -11,485,251 | -4,453,381 | -2,514,642 |
Ending Balance (Shares) at Dec. 31, 2010 | 35,313,202 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 11, 2011 for exercise of options at US$0.87per share | 8,700 | ' | ' | ' | ' | ' | 8,700 |
Issuance of common stock on January 11, 2011 for exercise of options at US$0.87per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 18, 2011 for exercise of options at US$1.15 per share | 69,000 | ' | ' | ' | ' | ' | 69,000 |
Issuance of common stock on January 18, 2011 for exercise of options at US$1.15 per share (Shares) | 60,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 27, 2011 for exercise of options at US$1.15 per share | 12,420 | ' | ' | ' | ' | ' | 12,420 |
Issuance of common stock on January 27, 2011 for exercise of options at US$1.15 per share (Shares) | 10,800 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 27, 2011 for exercise of options at US$0.87 per share | 1,544 | ' | ' | ' | ' | ' | 1,544 |
Issuance of common stock on January 27, 2011 for exercise of options at US$0.87 per share (Shares) | 1,775 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 31, 2011 for exercise of options at US$1.15 per share | 11,500 | ' | ' | ' | ' | ' | 11,500 |
Issuance of common stock on January 31, 2011 for exercise of options at US$1.15 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share | 11,500 | ' | ' | ' | ' | ' | 11,500 |
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share (second) | 2,875 | ' | ' | ' | ' | ' | 2,875 |
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share (second) (Shares) | 2,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 1, 2011 for exercise of options at US$0.87 per share | 2,175 | ' | ' | ' | ' | ' | 2,175 |
Issuance of common stock on February 1, 2011 for exercise of options at US$0.87 per share (Shares) | 2,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 10, 2011 for exercise of options at US$0.87 per share | 870 | ' | ' | ' | ' | ' | 870 |
Issuance of common stock on February 10, 2011 for exercise of options at US$0.87 per share (Shares) | 1,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 17, 2011 for exercise of options at US$1.12 per share | 28,000 | ' | ' | ' | ' | ' | 28,000 |
Issuance of common stock on February 17, 2011 for exercise of options at US$1.12 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 24, 2011 for exercise of warrants at US$1.25 per share | 62,500 | ' | ' | ' | ' | ' | 62,500 |
Issuance of common stock on February 24, 2011 for exercise of warrants at US$1.25 per share (Shares) | 50,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 25, 2011 for exercise of options at US$0.87 per share | 5,003 | ' | ' | ' | ' | ' | 5,003 |
Issuance of common stock on February 25, 2011 for exercise of options at US$0.87 per share (Shares) | 5,750 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 8, 2011 for exercise of options at US$0.87 per share | 4,094 | ' | ' | ' | ' | ' | 4,094 |
Issuance of common stock on March 8, 2011 for exercise of options at US$0.87 per share (Shares) | 4,706 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 10, 2011 for exercise of warrants at US$1.25 per share | 31,250 | ' | ' | ' | ' | ' | 31,250 |
Issuance of common stock on March 10, 2011 for exercise of warrants at US$1.25 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 16, 2011 for exercise of options at US$0.96 per share | 6,000 | ' | ' | ' | ' | ' | 6,000 |
Issuance of common stock on March 16, 2011 for exercise of options at US$0.96 per share (Shares) | 6,250 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 22, 2011 for exercise of options at US$1.12 per share | 22,400 | ' | ' | ' | ' | ' | 22,400 |
Issuance of common stock on March 22, 2011 for exercise of options at US$1.12 per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 25, 2011 for exercise of options at US$0.87 per share | 3,480 | ' | ' | ' | ' | ' | 3,480 |
Issuance of common stock on March 25, 2011 for exercise of options at US$0.87 per share (Shares) | 4,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 28, 2011 for exercise of warrants at CDN$1.20 per share | 15,700 | ' | ' | ' | ' | ' | 15,700 |
Issuance of common stock on March 28, 2011 for exercise of warrants at CDN$1.20 per share (Shares) | 14,273 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 29, 2011 for exercise of options at US$0.96 per share | 307,200 | ' | ' | ' | ' | ' | 307,200 |
Issuance of common stock on March 29, 2011 for exercise of options at US$0.96 per share (Shares) | 320,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 30, 2011 for exercise of options at US$0.96 per share | 28,800 | ' | ' | ' | ' | ' | 28,800 |
Issuance of common stock on March 30, 2011 for exercise of options at US$0.96 per share (Shares) | 30,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 7, 2011 for exercise of warrants at CDN$1.50 per share | 2,760 | ' | ' | ' | ' | ' | 2,760 |
Issuance of common stock on April 7, 2011 for exercise of warrants at CDN$1.50 per share (Shares) | 2,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 8, 2011 for exercise of options at US$0.87 per share | 8,700 | ' | ' | ' | ' | ' | 8,700 |
Issuance of common stock on April 8, 2011 for exercise of options at US$0.87 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 8, 2011 for exercise of options at $1.12 per share | 44,800 | ' | ' | ' | ' | ' | 44,800 |
Issuance of common stock on April 8, 2011 for exercise of options at $1.12 per share (Shares) | 40,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 14, 2011 for exercise of options at US$1.12 per share | 33,600 | ' | ' | ' | ' | ' | 33,600 |
Issuance of common stock on April 14, 2011 for exercise of options at US$1.12 per share (Shares) | 30,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 14, 2011 for exercise of options at US$1.02 per share | 11,730 | ' | ' | ' | ' | ' | 11,730 |
Issuance of common stock on April 14, 2011 for exercise of options at US$1.02 per share (Shares) | 11,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 19, 2011 for exercise of options at US$0.87 per share | 4,350 | ' | ' | ' | ' | ' | 4,350 |
Issuance of common stock on April 19, 2011 for exercise of options at US$0.87 per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 19, 2011 for exercise of warrants at CDN$1.95 per share | 9,750 | ' | ' | ' | ' | ' | 9,750 |
Issuance of common stock on April 19, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 21, 2011 for exercise of options at US$1.12 per share | 40,320 | ' | ' | ' | ' | ' | 40,320 |
Issuance of common stock on April 21, 2011 for exercise of options at US$1.12 per share (Shares) | 36,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 25, 2011 for exercise of warrants at CDN$1.50 per share | 9,849 | ' | ' | ' | ' | ' | 9,849 |
Issuance of common stock on April 25, 2011 for exercise of warrants at CDN$1.50 per share (Shares) | 7,137 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 25, 2011 for exercise of warrants at US$1.25 per share | 31,250 | ' | ' | ' | ' | ' | 31,250 |
Issuance of common stock on April 25, 2011 for exercise of warrants at US$1.25 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 28, 2011 for exercise of warrants at CDN$1.95 per share | 195,000 | ' | ' | ' | ' | ' | 195,000 |
Issuance of common stock on April 28, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 100,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 28, 2011 for exercise of options at US$1.12 per share | 56,000 | ' | ' | ' | ' | ' | 56,000 |
Issuance of common stock on April 28, 2011 for exercise of options at US$1.12 per share (Shares) | 50,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 2, 2011 for exercise of options at US$1.12 per share | 22,400 | ' | ' | ' | ' | ' | 22,400 |
Issuance of common stock on May 2, 2011 for exercise of options at US$1.12 per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 2, 2011 for exercise of warrants at CDN$1.95 per share | 63,484 | ' | ' | ' | ' | ' | 63,484 |
Issuance of common stock on May 2, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 32,556 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 4, 2011 for exercise of warrants at CDN$1.95 per share | 36,480 | ' | ' | ' | ' | ' | 36,480 |
Issuance of common stock on May 4, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 18,708 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share | 3,750 | ' | ' | ' | ' | ' | 3,750 |
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share (Shares) | 3,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share (second) | 62,500 | ' | ' | ' | ' | ' | 62,500 |
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share (second) (Shares) | 50,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 5, 2011 for exercise of warrants at CDN$1.95 per share | 16,251 | ' | ' | ' | ' | ' | 16,251 |
Issuance of common stock on May 5, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 8,334 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 5, 2011 for exercise of options at US$1.12 per share | 1,120 | ' | ' | ' | ' | ' | 1,120 |
Issuance of common stock on May 5, 2011 for exercise of options at US$1.12 per share (Shares) | 1,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 9, 2011 for exercise of warrants at US$1.25 per share | 36,080 | ' | ' | ' | ' | ' | 36,080 |
Issuance of common stock on May 9, 2011 for exercise of warrants at US$1.25 per share (Shares) | 28,864 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 10, 2011 for exercise of warrants at CDN$1.95 per share | 9,750 | ' | ' | ' | ' | ' | 9,750 |
Issuance of common stock on May 10, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.50 per share | 2,760 | ' | ' | ' | ' | ' | 2,760 |
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.50 per share (Shares) | 2,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.95 per share | 137,656 | ' | ' | ' | ' | ' | 137,656 |
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 70,593 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 17, 2011 for exercise of options at US$1.12 per share | 1,680 | ' | ' | ' | ' | ' | 1,680 |
Issuance of common stock on May 17, 2011 for exercise of options at US$1.12 per share (Shares) | 1,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 17, 2011 for exercise of warrants at CDN$1.95 per share | 10,834 | ' | ' | ' | ' | ' | 10,834 |
Issuance of common stock on May 17, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 5,556 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 19, 2011 for exercise of warrants at CDN$1.95 per share | 3,611 | ' | ' | ' | ' | ' | 3,611 |
Issuance of common stock on May 19, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 1,852 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 19, 2011 for exercise of options at US$1.12 per share | 1,344 | ' | ' | ' | ' | ' | 1,344 |
Issuance of common stock on May 19, 2011 for exercise of options at US$1.12 per share (Shares) | 1,200 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 24, 2011 for exercise of warrants at CDN$1.95 per share | 39,000 | ' | ' | ' | ' | ' | 39,000 |
Issuance of common stock on May 24, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN$1.20 per share | 38,456 | ' | ' | ' | ' | ' | 38,456 |
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN$1.20 per share (Shares) | 34,960 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN1.50 per share | 24,123 | ' | ' | ' | ' | ' | 24,123 |
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN1.50 per share (Shares) | 17,480 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 1 , 2011 for exercise of warrants at CDN1.95 per share | 223,575 | ' | ' | ' | ' | ' | 223,575 |
Issuance of common stock on June 1 , 2011 for exercise of warrants at CDN1.95 per share (Shares) | 114,654 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 9, 2011 for exercise of options at US$1.02 per share | 9,180 | ' | ' | ' | ' | ' | 9,180 |
Issuance of common stock on June 9, 2011 for exercise of options at US$1.02 per share (Shares) | 9,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 10, 2011 for exercise of warrants at CDN1.95 per share | 79,445 | ' | ' | ' | ' | ' | 79,445 |
Issuance of common stock on June 10, 2011 for exercise of warrants at CDN1.95 per share (Shares) | 40,741 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 13, 2011 for exercise of warrants at CDN1.95 per share | 59,588 | ' | ' | ' | ' | ' | 59,588 |
Issuance of common stock on June 13, 2011 for exercise of warrants at CDN1.95 per share (Shares) | 30,558 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN1.95 per share | 52,182 | ' | ' | ' | ' | ' | 52,182 |
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN1.95 per share (Shares) | 26,760 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN$1.50 per share | 6,900 | ' | ' | ' | ' | ' | 6,900 |
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN$1.50 per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.50 per share | 8,050 | ' | ' | ' | ' | ' | 8,050 |
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.50 per share (Shares) | 5,834 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.95 per share | 32,861 | ' | ' | ' | ' | ' | 32,861 |
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 16,852 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share | 227,529 | ' | ' | ' | ' | ' | 227,529 |
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 116,680 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share (second) | 110,573 | ' | ' | ' | ' | ' | 110,573 |
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share (second) (Shares) | 56,704 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 4, 2011 for exercise of warrants at CDN$1.95 per share | 113,442 | ' | ' | ' | ' | ' | 113,442 |
Issuance of common stock on July 4, 2011 for exercise of warrants at CDN$1.95 per share (Shares) | 58,175 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 5, 2011 for exercise of options at US$1.12 per share | 7,280 | ' | ' | ' | ' | ' | 7,280 |
Issuance of common stock on July 5, 2011 for exercise of options at US$1.12 per share (Shares) | 6,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 5, 2011 for exercise of options at US$1.02 per share | 10,200 | ' | ' | ' | ' | ' | 10,200 |
Issuance of common stock on July 5, 2011 for exercise of options at US$1.02 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 8, 2011 for cash $3.45 net of share issuance costs | 11,617,021 | 562,634 | ' | ' | ' | ' | 12,179,655 |
Issuance of common stock on July 8, 2011 for cash $3.45 net of share issuance costs (Shares) | 3,800,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 20, 2011 for exercise of warrants at CDN$3.45 per unit , net of commission | 729,622 | 18,386 | ' | ' | ' | ' | 748,008 |
Issuance of common stock on July 20, 2011 for exercise of warrants at CDN$3.45 per unit , net of commission (Shares) | 212,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 25, 2011 for exercise of options at US$1.12 per share | 1,680 | ' | ' | ' | ' | ' | 1,680 |
Issuance of common stock on July 25, 2011 for exercise of options at US$1.12 per share (Shares) | 1,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Sep 7, 2011 for exercise of options at US$1.12 per share | 2,800 | ' | ' | ' | ' | ' | 2,800 |
Issuance of common stock on Sep 7, 2011 for exercise of options at US$1.12 per share (Shares) | 2,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Oct 14, 2011 for exercise of options at US$1.45 per share | 725,000 | ' | ' | ' | ' | ' | 725,000 |
Issuance of common stock on Oct 14, 2011 for exercise of options at US$1.45 per share (Shares) | 500,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Oct 18, 2011 for exercise of options at US$0.87 per share | 17,400 | ' | ' | ' | ' | ' | 17,400 |
Issuance of common stock on Oct 18, 2011 for exercise of options at US$0.87 per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Nov 2, 2011 for exercise of options at US$1.02 per share | 2,040 | ' | ' | ' | ' | ' | 2,040 |
Issuance of common stock on Nov 2, 2011 for exercise of options at US$1.02 per share (Shares) | 2,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Nov 14, 2011 for exercise of options at US$1.12 per share | 4,200 | ' | ' | ' | ' | ' | 4,200 |
Issuance of common stock on Nov 14, 2011 for exercise of options at US$1.12 per share (Shares) | 3,750 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Nov 14, 2011 for exercise of options at US$0.87 per share | 5,437 | ' | ' | ' | ' | ' | 5,437 |
Issuance of common stock on Nov 14, 2011 for exercise of options at US$0.87 per share (Shares) | 6,250 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Nov 17, 2011 for exercise of options at US$1.12 per share | 2,240 | ' | ' | ' | ' | ' | 2,240 |
Issuance of common stock on Nov 17, 2011 for exercise of options at US$1.12 per share (Shares) | 2,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Nov 25, 2011 for exercise of options at US$0.95 per share | 23,750 | ' | ' | ' | ' | ' | 23,750 |
Issuance of common stock on Nov 25, 2011 for exercise of options at US$0.95 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Dec 5, 2011 for exercise of options at US$0.87 per share | 8,700 | ' | ' | ' | ' | ' | 8,700 |
Issuance of common stock on Dec 5, 2011 for exercise of options at US$0.87 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Dec 15, 2011 for exercise of options at US$0.87 per share | 6,525 | ' | ' | ' | ' | ' | 6,525 |
Issuance of common stock on Dec 15, 2011 for exercise of options at US$0.87 per share (Shares) | 7,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on Dec 19, 2011 for exercise of options at US$1.12 per share | 1,568 | ' | ' | ' | ' | ' | 1,568 |
Issuance of common stock on Dec 19, 2011 for exercise of options at US$1.12 per share (Shares) | 1,400 | ' | ' | ' | ' | ' | ' |
Transfer addition paid-in capital for options exercised in the year | 770,452 | -770,452 | ' | ' | ' | ' | ' |
Transfer derivative liability for warrants exercised in the year | 153,063 | ' | ' | ' | ' | ' | 153,063 |
Proceeds from issue of warrants | ' | 32,798 | ' | ' | ' | ' | 32,798 |
Stock-based compensation | ' | 2,561,066 | ' | ' | ' | ' | 2,561,066 |
Foreign currency translation | ' | ' | ' | -298,197 | ' | ' | -298,197 |
Net loss | ' | ' | ' | ' | ' | -6,998,922 | -6,998,922 |
Ending Balance at Dec. 31, 2011 | 27,428,844 | 5,174,834 | ' | -423,351 | -11,485,251 | -11,452,303 | 9,242,773 |
Ending Balance (Shares) at Dec. 31, 2011 | 41,701,604 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 16, 2012 for exercise of options at US$1.12per share | 67,200 | ' | ' | ' | ' | ' | 67,200 |
Issuance of common stock on January 16, 2012 for exercise of options at US$1.12per share (Shares) | 60,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 23, 2012 for exercise of options at US$1.12per share | 220,528 | ' | ' | ' | ' | ' | 220,528 |
Issuance of common stock on January 23, 2012 for exercise of options at US$1.12per share (Shares) | 196,900 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 24, 2012 for exercise of options at US$0.87per share | 17,400 | ' | ' | ' | ' | ' | 17,400 |
Issuance of common stock on January 24, 2012 for exercise of options at US$0.87per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 7, 2012 for exercise of options at US$0.87per share | 957 | ' | ' | ' | ' | ' | 957 |
Issuance of common stock on February 7, 2012 for exercise of options at US$0.87per share (Shares) | 1,100 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 16, 2012 for exercise of options at CDN$1.05per share | 2,205 | ' | ' | ' | ' | ' | 2,205 |
Issuance of common stock on February 16, 2012 for exercise of options at CDN$1.05per share (Shares) | 2,100 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 20, 2012 for exercise of options at US$0.87per share | 8,700 | ' | ' | ' | ' | ' | 8,700 |
Issuance of common stock on February 20, 2012 for exercise of options at US$0.87per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share | 101,000 | ' | ' | ' | ' | ' | 101,000 |
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share (Shares) | 100,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share (second) | 8,700 | ' | ' | ' | ' | ' | 8,700 |
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share (second) (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 28, 2012 for exercise of options at US$0.87per share | 4,350 | ' | ' | ' | ' | ' | 4,350 |
Issuance of common stock on February 28, 2012 for exercise of options at US$0.87per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 2, 2012 for exercise of warrants at CDN$1.50per share | 37,500 | ' | ' | ' | ' | ' | 37,500 |
Issuance of common stock on March 2, 2012 for exercise of warrants at CDN$1.50per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 2, 2012 for exercise of options at US$0.95per share | 23,750 | ' | ' | ' | ' | ' | 23,750 |
Issuance of common stock on March 2, 2012 for exercise of options at US$0.95per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 6, 2012 for exercise of options at US$0.87per share | 4,350 | ' | ' | ' | ' | ' | 4,350 |
Issuance of common stock on March 6, 2012 for exercise of options at US$0.87per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 8, 2012 for exercise of options at CDN$1.05per share | 630 | ' | ' | ' | ' | ' | 630 |
Issuance of common stock on March 8, 2012 for exercise of options at CDN$1.05per share (Shares) | 600 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 15, 2012 for exercise of warrants at CDN$1.25per share | 291,600 | ' | ' | ' | ' | ' | 291,600 |
Issuance of common stock on March 15, 2012 for exercise of warrants at CDN$1.25per share (Shares) | 250,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 15, 2012 for exercise of options at CDN$1.05per share | 5,775 | ' | ' | ' | ' | ' | 5,775 |
Issuance of common stock on March 15, 2012 for exercise of options at CDN$1.05per share (Shares) | 5,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 15, 2012 for exercise of options at CDN$0.87per share | 4,350 | ' | ' | ' | ' | ' | 4,350 |
Issuance of common stock on March 15, 2012 for exercise of options at CDN$0.87per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 23, 2012 for exercise of options at CDN$0.87per share | 4,350 | ' | ' | ' | ' | ' | 4,350 |
Issuance of common stock on March 23, 2012 for exercise of options at CDN$0.87per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 29, 2012 for exercise of warrants at CDN$1.50 per share | 22,500 | ' | ' | ' | ' | ' | 22,500 |
Issuance of common stock on March 29, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 15,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 3, 2012 for exercise of options at US$0.96per share | 42,000 | ' | ' | ' | ' | ' | 42,000 |
Issuance of common stock on April 3, 2012 for exercise of options at US$0.96per share (Shares) | 43,750 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 3, 2012 for exercise of options at CDN$2.74per share | 40,770 | ' | ' | ' | ' | ' | 40,770 |
Issuance of common stock on April 3, 2012 for exercise of options at CDN$2.74per share (Shares) | 14,585 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 3, 2012 for exercise of warrants at CDN$1.50 per share | 30,000 | ' | ' | ' | ' | ' | 30,000 |
Issuance of common stock on April 3, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 4, 2012 for exercise of options at US$0.87per share | 8,695 | ' | ' | ' | ' | ' | 8,695 |
Issuance of common stock on April 4, 2012 for exercise of options at US$0.87per share (Shares) | 9,994 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 12, 2012 for exercise of options at CDN$1.05per share | 1,050 | ' | ' | ' | ' | ' | 1,050 |
Issuance of common stock on April 12, 2012 for exercise of options at CDN$1.05per share (Shares) | 1,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 13, 2012 for exercise of warrants at CDN$1.25 per share | 3,750 | ' | ' | ' | ' | ' | 3,750 |
Issuance of common stock on April 13, 2012 for exercise of warrants at CDN$1.25 per share (Shares) | 3,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 15, 2012 for exercise of warrants at CDN$1.50 per share | 7,500 | ' | ' | ' | ' | ' | 7,500 |
Issuance of common stock on May 15, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.50 per share | 15,000 | ' | ' | ' | ' | ' | 15,000 |
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.25 per share | 2,500 | ' | ' | ' | ' | ' | 2,500 |
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.25 per share (Shares) | 2,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 4, 2012 for exercise of warrants at CDN$1.50 per share | 2,250 | ' | ' | ' | ' | ' | 2,250 |
Issuance of common stock on June 4, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 1,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 11, 2012 for exercise of options at CDN$0.87per share | 1,088 | ' | ' | ' | ' | ' | 1,088 |
Issuance of common stock on June 11, 2012 for exercise of options at CDN$0.87per share (Shares) | 1,250 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on June 11, 2012 for exercise of options at US$1.03per share | 10,300 | ' | ' | ' | ' | ' | 10,300 |
Issuance of common stock on June 11, 2012 for exercise of options at US$1.03per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 4, 2012 for exercise of options at US$1.17per share | 8,775 | ' | ' | ' | ' | ' | 8,775 |
Issuance of common stock on July 4, 2012 for exercise of options at US$1.17per share (Shares) | 7,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 9, 2012 for exercise of options at US$1.01per share | 63,125 | ' | ' | ' | ' | ' | 63,125 |
Issuance of common stock on July 9, 2012 for exercise of options at US$1.01per share (Shares) | 62,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 13, 2012 for exercise of options at US$1.01per share | 63,125 | ' | ' | ' | ' | ' | 63,125 |
Issuance of common stock on July 13, 2012 for exercise of options at US$1.01per share (Shares) | 62,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on July 19, 2012 for exercise of warrants at CDN$1.50 per share | 62,501 | ' | ' | ' | ' | ' | 62,501 |
Issuance of common stock on July 19, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 41,667 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on August 30, 2012 for exercise of warrants at CDN$1.50 per share | 3,750 | ' | ' | ' | ' | ' | 3,750 |
Issuance of common stock on August 30, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 2,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on August 30, 2012 for exercise of options at CDN$0.87per share | 8,222 | ' | ' | ' | ' | ' | 8,222 |
Issuance of common stock on August 30, 2012 for exercise of options at CDN$0.87per share (Shares) | 9,450 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 6, 2012 for exercise of options at US$0.96per share | 19,200 | ' | ' | ' | ' | ' | 19,200 |
Issuance of common stock on September 6, 2012 for exercise of options at US$0.96per share (Shares) | 20,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 6, 2012 for exercise of options at US$1.17per share | 11,700 | ' | ' | ' | ' | ' | 11,700 |
Issuance of common stock on September 6, 2012 for exercise of options at US$1.17per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 12, 2012 for exercise of warrants at CDN$1.50 per share | 3,750 | ' | ' | ' | ' | ' | 3,750 |
Issuance of common stock on September 12, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 2,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 12, 2012 for exercise of warrants at US$1.38 per share | 2,760 | ' | ' | ' | ' | ' | 2,760 |
Issuance of common stock on September 12, 2012 for exercise of warrants at US$1.38 per share (Shares) | 2,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 13, 2012 for cash - USD$2.21, net of share issue costs | 889,383 | ' | ' | ' | ' | ' | 889,383 |
Issuance of common stock on September 13, 2012 for cash - USD$2.21, net of share issue costs (Shares) | 418,429 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 17, 2012 for exercise of warrants at US$1.38 per share | 20,700 | ' | ' | ' | ' | ' | 20,700 |
Issuance of common stock on September 17, 2012 for exercise of warrants at US$1.38 per share (Shares) | 15,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.30 per share | 28,392 | ' | ' | ' | ' | ' | 28,392 |
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.30 per share (Shares) | 21,840 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.50 per share | 3,126 | ' | ' | ' | ' | ' | 3,126 |
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 2,084 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 19, 2012 for exercise of warrants at US$1.38 per share | 207,000 | ' | ' | ' | ' | ' | 207,000 |
Issuance of common stock on September 19, 2012 for exercise of warrants at US$1.38 per share (Shares) | 150,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 21, 2012 for exercise of warrants at US$1.38 per share | 69,000 | ' | ' | ' | ' | ' | 69,000 |
Issuance of common stock on September 21, 2012 for exercise of warrants at US$1.38 per share (Shares) | 50,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 21, 2012 for exercise of warrants at CDN$1.50 per share | 44,250 | ' | ' | ' | ' | ' | 44,250 |
Issuance of common stock on September 21, 2012 for exercise of warrants at CDN$1.50 per share (Shares) | 29,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on September 24, 2012 for cash - USD$2.21, net of share issue costs | 958,100 | ' | ' | ' | ' | ' | 958,100 |
Issuance of common stock on September 24, 2012 for cash - USD$2.21, net of share issue costs (Shares) | 450,758 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on October 10, 2012 for cash - USD$2.21, net of share issue costs | 438,877 | ' | -64,050 | ' | ' | ' | 374,827 |
Issuance of common stock on October 10, 2012 for cash - USD$2.21, net of share issue costs (Shares) | 198,587 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on October 17, 2012 for exercise of options at US$1.17per share | 8,775 | ' | ' | ' | ' | ' | 8,775 |
Issuance of common stock on October 17, 2012 for exercise of options at US$1.17per share (Shares) | 7,500 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on November 2, 2012 for exercise of options at US$0.96per share | 96,000 | ' | ' | ' | ' | ' | 96,000 |
Issuance of common stock on November 2, 2012 for exercise of options at US$0.96per share (Shares) | 100,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on November 20, 2012 for exercise of options at US$1.17per share | 11,700 | ' | ' | ' | ' | ' | 11,700 |
Issuance of common stock on November 20, 2012 for exercise of options at US$1.17per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Transfer addition paid-in capital for options exercised in the year | 511,247 | -511,247 | ' | ' | ' | ' | ' |
Set up derivative liabilities for warrants granted in the year | -280,496 | ' | ' | ' | ' | ' | -280,496 |
Transfer derivative liability for warrants exercised in the year | 873,728 | ' | ' | ' | ' | ' | 873,728 |
Transfer derivative liability for warrants expired in the year | 70,514 | ' | ' | ' | ' | ' | 70,514 |
Stock-based compensation | ' | 2,397,819 | ' | ' | ' | ' | 2,397,819 |
Foreign currency translation | ' | ' | ' | -35,685 | ' | ' | -35,685 |
Net loss | ' | ' | ' | ' | ' | -9,315,360 | -9,315,360 |
Ending Balance at Dec. 31, 2012 | 32,616,795 | 7,061,406 | -64,050 | -459,036 | -11,485,251 | -20,767,663 | 6,902,201 |
Ending Balance (Shares) at Dec. 31, 2012 | 44,239,198 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 9, 2013 for exercise of options at US $1.17per share | 5,850 | ' | ' | ' | ' | ' | 5,850 |
Issuance of common stock on January 9, 2013 for exercise of options at US $1.17per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on January 22, 2013 for exercise of options at US$1.02per share | 26,520 | ' | ' | ' | ' | ' | 26,520 |
Issuance of common stock on January 22, 2013 for exercise of options at US$1.02per share (Shares) | 26,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 5, 2013 for exercise of options at US$1.17per share | 5,850 | ' | ' | ' | ' | ' | 5,850 |
Issuance of common stock on February 5, 2013 for exercise of options at US$1.17per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on February 13, 2013 for exercise of options at CAD$0.95 per share | 23,750 | ' | ' | ' | ' | ' | 23,750 |
Issuance of common stock on February 13, 2013 for exercise of options at CAD$0.95 per share (Shares) | 25,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 1, 2013 for exercise of options at CAD $0.96 per share | 116,951 | ' | ' | ' | ' | ' | 116,951 |
Issuance of common stock on March 1, 2013 for exercise of options at CAD $0.96 per share (Shares) | 120,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 8, 2013 for exercise of options at CAD $0.96 per share | 9,600 | ' | ' | ' | ' | ' | 9,600 |
Issuance of common stock on March 8, 2013 for exercise of options at CAD $0.96 per share (Shares) | 10,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on March 23, 2013 for exercise of options at CAD$0.87 per share | 4,350 | ' | ' | ' | ' | ' | 4,350 |
Issuance of common stock on March 23, 2013 for exercise of options at CAD$0.87 per share (Shares) | 5,000 | ' | ' | ' | ' | ' | ' |
Issuance of common stock on April 16, 2013 for exercise of warrants | 46,875 | ' | ' | ' | ' | ' | 46,875 |
Issuance of common stock on April 16, 2013 for exercise of warrants (Shares) | 37,500 | ' | ' | ' | ' | ' | ' |
Transfer addition paid-in capital for options exercised in the year | 118,239 | -118,239 | ' | ' | ' | ' | ' |
Debenture warrants | ' | 754,829 | ' | ' | ' | ' | 754,829 |
Adjustment to warrant conversion price | ' | 79,931 | ' | ' | ' | ' | 79,931 |
Issuance costs of debenture warrants | ' | -102,670 | ' | ' | ' | ' | -102,670 |
Issuance costs of long term debt and debenture warrants brokers warrants | ' | 66,278 | ' | ' | ' | ' | 66,278 |
Transfer from derivative liability warrants exercise | 35,190 | ' | ' | ' | ' | ' | 35,190 |
Private placement | 1,879,400 | ' | ' | ' | ' | ' | 1,879,400 |
Private placement (Shares) | 3,333,333 | ' | ' | ' | ' | ' | ' |
Stock-based compensation | ' | 2,004,647 | ' | ' | ' | ' | 2,004,647 |
Beneficial conversion feature on notes payable | ' | 188,140 | ' | ' | ' | ' | 188,140 |
Write off of subscription receivable | ' | ' | 64,050 | ' | ' | ' | 64,050 |
Foreign currency translation | ' | ' | ' | 1,044,337 | ' | ' | 1,044,337 |
Net loss | ' | ' | ' | ' | ' | -15,169,933 | -15,169,933 |
Ending Balance at Dec. 28, 2013 | $34,889,370 | $9,934,322 | ' | $585,301 | ($11,485,251) | ($35,937,596) | ($2,013,854) |
Ending Balance (Shares) at Dec. 28, 2013 | 47,806,031 | ' | ' | ' | ' | ' | ' |
Nature_of_Operations_and_Basis
Nature of Operations and Basis of Presentation | 12 Months Ended | |
Dec. 28, 2013 | ||
Nature of Operations and Basis of Presentation [Text Block] | ' | |
1 | Nature of Operations and Basis of Presentation | |
CRAiLAR Technologies Inc. (the “Company”) was incorporated in the Province of British Columbia, Canada, on October 6, 1998, and is in the business of technological development and of natural sustainable fibers. Effective October 1, 2009, the Company decided to exit the apparel business, which operated under the brand “HTnaturals”. As a result, the Company re-entered the development stage and has focused on its CRAiLAR ® technology. | ||
The Company’s shares of common stock trade under the symbol “CL”, on the TSX Venture Exchange (“TSX-V”) and under the symbol “CRLRF” on the OTCQB. | ||
Going concern | ||
The Company’s consolidated financial statements are prepared using generally accepted accounting principles (“GAAP”) in the United States of America applicable to a going concern, which contemplates the realization of assets and payment of liabilities in the normal course of business. The Company has incurred losses since inception of $47,422,847 and further losses are anticipated in the development of its business. There can be no assurance that the Company will be able to achieve or maintain profitability. Accordingly, these factors raise doubt as to the Company’s ability to continue as a going concern. During 2013 the Company raised $2,119,146 from equity funding for capacity expansion and working capital requirements. The Company plans to raise additional financing in 2014 through equity placements for future capacity expansion. However, there can be no assurance that capital will be available or, if the capital is available, that it will be on terms acceptable to the Company. |
Significant_Accounting_Policie
Significant Accounting Policies | 12 Months Ended | ||
Dec. 28, 2013 | |||
Significant Accounting Policies [Text Block] | ' | ||
2 | Significant Accounting Policies | ||
a) | Principles of Consolidation | ||
The consolidated financial statements include the accounts of the Company and its five wholly-owned subsidiaries as of December 28, 2013: Crailar Inc., a Nevada incorporated company; Hemptown USA, Inc., a Nevada incorporated company; 0697872 B.C. Ltd., a British Columbia incorporated company; Crailar Fiber Technologies Inc., a British Columbia incorporated company, and HTNaturals Apparel Corp, a British Columbia incorporated company. All inter-company transactions and account balances have been eliminated upon consolidation. | |||
b) | Cash and Cash Equivalents | ||
Cash equivalents consist of cash on deposit and term deposits with original maturities of one year or less at the time of issuance. As at December 28, 2013, the Company held $15,000 (2012 - $20,000) in cash equivalents. | |||
c) | Inventory | ||
The raw flax fiber feedstock, decorticated fiber and Crailar fiber is valued at the lower of cost and market. All direct costs are capitalized to raw flax fiber inventory, decorticated fiber inventory and Crailar fiber. | |||
Seed inventory was valued at the lower of average cost and market. Cost comprised the cost to purchase seed and/or growing cost plus any related shipping costs. | |||
Other inventories, which consists of production consumables, are recorded at the lower of cost and replacement cost which approximates net realizable value. | |||
d) | Use of Estimates | ||
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Significant areas requiring management’s estimates and assumptions are inventory costing and net realizable value, the expected future use and other impairment considerations of property and equipment, fair value of warrants, options, derivative liabilities, provision for income taxes, depreciation and financial instruments. | |||
e) | Property and Equipment | ||
Property and equipment are stated at cost and are depreciated as follows: | |||
Automobiles | 20% declining balance | ||
Computer equipment | 30% declining balance | ||
Computer software | 100% declining balance | ||
Equipment | 30% declining balance | ||
Furniture and fixtures | 20% declining balance | ||
Production Equipment | 30% declining balance | ||
Leasehold improvements | Term of lease | ||
Website development | 100% declining balance | ||
Depreciation is claimed at one-half of the regular rate in the year of addition, no depreciation is claimed in the year of disposal. | |||
f) | Intangible Assets | ||
Intangible assets are stated at cost and are amortized as follows: | |||
Trademarks | 5 year straight - line | ||
License Fee | 10 year straight - line | ||
Patent | 10 year straight – lin | ||
g) | Revenue Recognition | ||
Revenue is recognized when there is persuasive evidence of a sale arrangement, delivery to the customer has occurred, the fee is fixed and determinable, and collectability is considered probable. | |||
h) | Foreign Currency Translation | ||
The Company’s functional currency is Canadian dollars. The Company translates its financial statements to U.S. dollars using the following method: | |||
All assets and liabilities are translated into U.S. dollars at the exchange rate in effect at the year-end. Revenues and expenses are translated throughout the year at the weighted average exchange rate. Exchange gains or losses from such translations are included in accumulated comprehensive income (loss), as a separate component of stockholders’ equity. | |||
Foreign currency transaction gains and losses are included in the statement of operations and comprehensive loss. | |||
i) Income Taxes | |||
The Company utilizes the liability method of accounting for deferred income taxes. Under the liability method, deferred income taxes are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates. A valuation allowance is recorded when it is more likely than not that potential the future tax assets will not be realized. | |||
j) Comprehensive Loss | |||
Comprehensive loss is the change in equity during a period resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Other comprehensive income (loss) comprises items of income and expenses that are not recognized in net loss as required or permitted by GAAP. | |||
k) Stock-based Compensation | |||
The Company accounts for stock-based payment transactions in which an enterprise receives services in exchange for (a) equity instruments of the enterprise or (b) liabilities that are based on the fair value of the enterprise’s equity instruments or that may be settled by the issuance of such equity instruments. The Company uses the Black-Scholes option-pricing model to establish the fair-value of stock-based awards. | |||
l) Earnings (Loss) Per Share | |||
Basic and diluted earnings (loss) per share are computed using the weighted average number of shares outstanding during the year. Common stock equivalents from stock options and warrants were excluded from the calculation of net loss per share for the years ended December 28, 2013 and December 31, 2012 as their effect is anti-dilutive. | |||
m) Long-Lived Asset Impairment | |||
Long-lived assets of the Company are reviewed when changes in circumstances suggest their carrying value has become impaired. Management considers assets to be impaired if the carrying value exceeds the estimated discounted future projected cash flows to result from the use of the asset and its eventual disposition. If impairment is deemed to exist, the assets will be written down to fair value. Fair value is generally determined using a hierarchy of fair value methodologies under GAAP, primarily based on a discounted cash flow analysis. | |||
n) Risk Management | |||
Currency risk. The Company is exposed to currency risk to the extent that certain inventory and equipment is purchased from Europe. The purchase price for such inventory and equipment is generally in Euros. The Company does not currently hedge its foreign currency exposure, and accordingly, is at risk for foreign currency exchange fluctuations. The Company and its subsidiaries do not have significant transactions or hold significant cash denominated in currencies other than their functional currencies. | |||
Credit risk. The risk in cash accounts is managed through the use of a major financial institution, which has high credit quality as determined by the rating agencies. As at December 28, 2013, $158,000 is due from a single customer and therefore 61% of receivables are exposed to concentration of credit risk. | |||
Interest rate risk. Approximately $1,026,000 of the Company’s debt bears interest at fluctuating rates. Consequentially the Company is exposed to interest rate fluctuations. The Company does not currently hedge its exposure to interest rate risk. | |||
Commodity price risk. Commodity price risk is the risk that the fair value of future cash flows will fluctuate because of changes in the market prices of commodities. The Company is exposed to commodity price risk as it purchases fiber feedstock from the flax producers in Europe. The Company purchases the short fiber waste product called “tow” and the price fluctuates based on supply. The Company has relationships with several short fiber producers and anticipates little issue in obtaining sufficient fiber for its needs. The Company does not currently enter into futures contracts or otherwise hedge its exposure to commodity price risk. | |||
o) Research and Development | |||
Research and development costs are charged to operations as incurred. | |||
p) Recent Pronouncements There are no recent pronouncements that are applicable to the Company. |
Financial_Instruments
Financial Instruments | 12 Months Ended | |
Dec. 28, 2013 | ||
Financial Instruments [Text Block] | ' | |
3 | Financial Instruments | |
As at December 28, 2013, the Company concluded that the carrying amount of cash and cash equivalents, receivables, accounts payable, and notes payable to approximate fair value because of the short maturity of these financial instruments. The Company has concluded that the carrying amount of loans payable and long-term debt approximate fair value as they bear interest at market rates. Derivative liabilities are recorded at fair value. |
Inventory
Inventory | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Inventory [Text Block] | ' | ||||||
4 | Inventory | ||||||
28-Dec-13 | 31-Dec-12 | ||||||
CRAiLAR fiber | $ | 186,464 | $ | - | |||
Decorticated fiber | 252,263 | 51,504 | |||||
Flax seed | - | 1,172,155 | |||||
Raw flax fiber feedstock | 369,590 | 1,680,993 | |||||
Other | 136,723 | - | |||||
$ | 945,040 | $ | 2,904,652 | ||||
The Company wrote down inventory by the following amounts to reduce the book value to net realizable value: | |||||||
28-Dec-13 | 31-Dec-12 | ||||||
CRAiLAR fiber | $ | 274,297 | $ | - | |||
Decorticated fiber | 196,861 | - | |||||
Flax seed | 1,891,217 | 303,663 | |||||
Raw flax fiber feedstock | 2,279,887 | - | |||||
$ | 4,642,262 | $ | 303,663 |
Property_and_Equipment
Property and Equipment | 12 Months Ended | ||||||||||||
Dec. 28, 2013 | |||||||||||||
Property and Equipment [Text Block] | ' | ||||||||||||
5 | Property and Equipment | ||||||||||||
Net Book Value | Net Book Value | ||||||||||||
Accumulated | December 28, | December 31, | |||||||||||
Cost | Depreciation | 2013 | 2012 | ||||||||||
Automobiles | $ | 58,743 | $ | 8,876 | $ | 49,867 | $ | 57,559 | |||||
Computer equipment | 126,192 | 69,019 | 57,180 | 48,398 | |||||||||
Equipment | 754,902 | 98,556 | 656,346 | 359,445 | |||||||||
Equipment held for sale | 70,000 | - | 70,000 | 105,045 | |||||||||
Furniture and fixtures | 62,339 | 36,918 | 25,421 | 29,980 | |||||||||
Leasehold improvements | 6,327,333 | 615,459 | 5,498,633 | 4,979,548 | |||||||||
Production equipment | 5,095,961 | 277,681 | 4,818,280 | - | |||||||||
Production equipment in construction | 6,060,849 | - | 6,060,849 | 7,606,837 | |||||||||
Website development costs | 121,330 | 117,365 | 3,436 | 61,876 | |||||||||
$ | 18,464,408 | $ | 1,224,396 | $ | 17,240,012 | $ | 13,248,688 | ||||||
Depreciation of production equipment and leasehold improvements commenced on January 1, 2013 as the Company’s manufacturing facility started production. In August, the company temporarily ceased production and therefore ceased amortization expense on the assets that were not in use. |
Intangible_Assets
Intangible Assets | 12 Months Ended | ||||||||||||
Dec. 28, 2013 | |||||||||||||
Intangible Assets [Text Block] | ' | ||||||||||||
6 | Intangible Assets | ||||||||||||
Accumulated | Net Book Value | Net Book Value | |||||||||||
Cost | Amortization | 28-Dec-13 | 31-Dec-12 | ||||||||||
Patents | $ | 158,367 | $ | 72,885 | $ | 85,482 | $ | 77,961 | |||||
Trademarks | 121,968 | 93,903 | 28,065 | 7,639 | |||||||||
License fee | 62,710 | 20,712 | 41,998 | 9,019 | |||||||||
$ | 343,045 | $ | 187,500 | $ | 155,545 | $ | 94,619 |
Derivative_liability
Derivative liability | 12 Months Ended | |||||||||
Dec. 28, 2013 | ||||||||||
Derivative liability [Text Block] | ' | |||||||||
7 | Derivative liability | |||||||||
Derivate liability consists of warrants that were issued in private placements which have exercise prices denominated in a currency other than the Canadian dollar, the Company’s functional currency. This derivative liability is a non-cash liability which the Company is not required to expend any cash to settle. The fair value of the warrants are as follows: | ||||||||||
December 28, | December 31, | |||||||||
Exercise price | 2013 | 2012 | ||||||||
275,506 warrants expired on May 19, 2013 | US$1.25 | $ | - | $ | 257,564 | |||||
533,887 warrants expiring on Oct 14, 2014 | US$3.45 | - | 230,471 | |||||||
$ | - | $ | 488,035 | |||||||
The fair value of these warrants was determined using the Black-Scholes option pricing model, using the following assumptions: | ||||||||||
28-Dec-13 | 31-Dec-12 | |||||||||
Volatility | 60% | 57% - 83% | ||||||||
Dividend yield | - | - | ||||||||
Risk-free interest rate | 0.09% | 0.14 – 0.72% | ||||||||
Expected life | 0.62 years | 0.38 – 1.18 yrs. | ||||||||
During the year ended December 28, 2013, 37,500 warrants were exercised and the Company recognized $35,190 of the derivative liability in share capital. |
Notes_Payable
Notes Payable | 12 Months Ended | |||
Dec. 28, 2013 | ||||
Notes Payable [Text Block] | ' | |||
8 | Notes Payable | |||
28-Dec-13 | ||||
Principal | $ | 669,335 | ||
Interest | 23,781 | |||
Repayment | (47,885 | ) | ||
Beneficial conversion feature | (188,140 | ) | ||
Accretion expense | 33,495 | |||
Effect of foreign exchange | (13,872 | ) | ||
$ | 476,614 | |||
On October 11, 2013, the Company issued a demand convertible promissory note in favor of Mr. Robert Edmunds, one of its directors, in the principal amount of $467,369 (CAD$500,000). On December 4, 2013, | ||||
the Company issued an additional demand convertible promissory note in favor of Mr. Robert Edmunds, pursuant to a loan from Mr. Robert Edmunds to the Company in the principal amount of $42,255 (CAD$45,000). The promissory notes bear interest on the principle amount at a rate of 20% per annum, is unsecured and payable in full on repayment of the principal amount. The convertible promissory note included 181,666 bonus common shares of the Company, subject to TSX-V approval which was received subsequent to year end (Note 16). At December 28, 2013 the balance outstanding, including accrued interest of $20,896 (CAD$22,667), was $532,576 (CAD$567,267). | ||||
On October 11, 2013, the Company issued a convertible promissory note in favor of Mr. Jason Finnis, one of its directors, in the principal amount of $96,180 (CAD$100,000). The promissory notes bear interest on the principal amount at the rate of 12% per annum, is unsecured and payable in full on repayment of the principle amount. On November 7, 2013, the company repaid Mr. Jason Finnis $48,326 (CAD$50,000) of principal including interest of $441 (CAD$460). At December 28, 2013, the balance outstanding, include accrued interest of $1,210 (CAD$1,290), was $48,132 (CAD$51,290). | ||||
On October 11, 2013, the Company issued a convertible promissory note in favor of Mr. Kenneth Barker, one of its directors, in the principal amount of $50,000. The promissory note bears interest on the principle amount at the rate of 12% per annum, is unsecured and payable in full on repayment of the principal amount. At December 28, 2013, the outstanding balance, including accrued interest of $1,234, was $51,234. | ||||
The promissory notes issued during the year ended December 28, 2013 contain conversion features. Each lender has the right to convert any portion of the outstanding principal and interest payables for units at an exercise price of $0.60 per unit. Each unit is comprised of one common share and one common share purchase warrant of the Company. Each warrant entitles the holder to acquire one common share of the Company at an exercise price of CAD$0.70 per common share for a term of five years. The Company recognized a beneficial conversion feature of $188,140 (CAD$200,000) based on the excess of the conversion price over the commitment date fair value of the stock. The Company incurred an accretion expense of $33,495 (CAD$34,483) during the year reducing the value of the beneficial conversion feature to a balance of $154,645 (CAD$165,517). | ||||
The promissory notes issued during the year ended December 28, 2013 mature on the earliest of December 20, 2014 or at such time the Company completes a public offering of registered securities by way of registration statement on Form S-1 of not less than CAD$3,000,000 in gross proceeds. |
Long_term_debt
Long term debt | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Long term debt [Text Block] | ' | ||||||
9 | Long term debt | ||||||
Long term debt: | |||||||
28-Dec-13 | 31-Dec-12 | ||||||
Balance, beginning | $ | 10,051,262 | $ | - | |||
Convertible debenture issued | 8,307,249 | 10,051,262 | |||||
Discount on debentures | (754,829 | ) | - | ||||
Amendment of debentures – conversion price | (79,931 | ) | - | ||||
Accretion expense | 94,030 | - | |||||
Effect of foreign exchange | (943,095 | ) | - | ||||
Balance, ending | $ | 16,674,686 | $ | 10,051,262 | |||
Deferred debt issuance costs: | |||||||
28-Dec-13 | 31-Dec-12 | ||||||
Balance, beginning | $ | 1,024,294 | $ | - | |||
Issuance costs – cash | 886,733 | 1,083,936 | |||||
Issuance costs – warrants | 66,278 | - | |||||
Issuance costs allocated to additional paid in capital | (102,670 | ) | - | ||||
Amortization of issuance costs | (346,789 | ) | (59,642 | ) | |||
Effect of foreign exchange | (85,823 | ) | - | ||||
$ | 1,442,023 | $ | 1,024,294 | ||||
On September 20, 2012, the Company completed the offering of $10,051,262 (CAD$10,000,000) convertible debentures (the “2012 Notes”). The 2012 Notes mature on September 20, 2017. The 2012 Notes bear interest at a rate of 10% per year, payable semi-annually on March 31 and September 30, starting March 31, 2013. As at December 28, 2013, accrued interest of $264,143 (2012 - $277,513) (CAD$281,471) (2012 – CAD$277,397) was included in accrued liabilities. During the year ended December 31, 2012, the Company paid a total of $1,083,936 (CAD$1,019,069) in cash issuance costs which have been recorded as deferred debt issuance costs. | |||||||
On February 26, 2013, the Company completed an offering of $4,943,643 (CAD$5,000,000) convertible debentures (the “2013 Notes”). The 2013 Notes mature on September 30, 2017. The 2013 Notes bear interest at a rate of 10% per year, payable semi-annually on March 31 and September 30, starting September 30, 2013. As at December 28, 2013, accrued interest of $114,412 (CAD$121,918) was included in accrued liabilities. The Company paid a total of $427,049 (CAD$487,830) in cash issuance costs which have been recorded as deferred debt issuance costs. | |||||||
Holders of the 2012 Notes and 2013 Notes have the option to convert at a price of $2.85 (CAD$2.90) per common shares in the capital of the Company at any time prior to the maturity date. The Company may redeem the 2012 Notes and the 2013 Notes after September 30, 2015 provided that the market price at the time of the redemption notice is not less than 125% of the conversion price. The conversion rate is subject to standard anti-dilution provisions. | |||||||
The 2012 Notes and 2013 Notes are secured by a Guaranty and Security Agreement signed with the Company’s wholly-owned subsidiary, Crailar Inc. (“CI”), a Nevada incorporated company. CI provides a security interest over its assets, having an aggregate acquisition cost of no less than $5,500,000, as security for its guarantee obligation which shall rank in priority to all other indebtedness of CI. | |||||||
The 2012 Notes and 2013 Notes do not contain a beneficial conversion feature, as the fair value of the Company’s common stock on the date of issuance was less than the conversion price. All proceeds from the notes were recorded as a debt instrument. | |||||||
On July 26, 2013, the Company closed a convertible debenture offering for gross proceeds of $3,363,606 (CAD$3,535,000) (the “2013A Notes”). The 2013A Notes will mature on July 26, 2016 and will accrue interest at a rate of 10% per year, payable semi-annually in arrears on March 31 and September 30 commencing September 30, 2013. As at December 28, 2013, accrued interest of $80,893 (CAD$86,200) was included in accrued liabilities. At the holder’s option, the debentures may be converted into common shares in the capital of the Company at any time up to the earlier of the maturity date and the business day immediately preceding the date specified by the Company for redemption of the debentures. The conversion price, will be CAD$1.25 per share. | |||||||
In addition, the Company issued 800 transferable common share purchase warrants (each, a “Warrant”) for each CAD$1,000 of principal amount, resulting in an aggregate of 2,828,000 Warrants, with each Warrant entitling the holder thereof to purchase one additional Share (each, a “Warrant Share”) at an exercise price of $2.00 per Warrant Share until July 26, 2016. The Company determined the fair value of the warrants to be $974,387 (CAD$1,003,910) using the Black-Scholes Option Pricing Model with the following assumptions: Expected dividend yield – 0; expected stock price volatility – 56%; risk-free interest rate – 0.59%; expected life – 2.83 years. | |||||||
The proceeds were allocated to the 2013A Notes and the Warrants based on their relative fair values and accordingly, $2,295,309 (CAD$2,757,300) was allocated to the 2103A Notes and $754,829 (CAD$777,700) was allocated to the Warrants and recorded as a reduction in the 2013A Notes and an increase in additional paid-in capital. | |||||||
The Company incurred a total of $440,139 in issuance and commission costs relating to the 2013A Notes. This included $373,861 in cash issuance costs and the fair value of 192,360 broker’s warrants of $66,278. Each broker’s warrant entitles the holder to purchase one common share for $1.25 per share for three years from the date of issuance. The fair value of the brokers’ warrants was calculated using the Black-Scholes Option Pricing Model with the following assumptions: expected dividend yield – 0; expected stock price volatility – 56%; risk-free interest rate – 0.59%; expected life – 2.83 years. The allocation of the 2013A Note issuance costs were based on the relative fair value of the 2013A Notes and the Warrants accordingly, $337,469 was allocated to deferred debt issuance costs and $102,670 was allocated to additional paid-in capital. | |||||||
The 2013A Notes included a continuing security interest in the Company’s assets. On December 17, 2013 the Guaranty and Security Agreement was amended to only include certain specific assets held by the Company which had an acquisition cost of $3,922,240. As consideration for the modification, the conversion price of the debentures was amended to $1.25 per warrant. The Company determined the fair value of the additional debt discount to be $79,931 using the Black-Scholes Option Pricing Model with the following assumptions: Expected dividend yield – 0; Expected stock price volatility – 56%; Risk-free interest rate – 0.59%; Expected life – 2.42 years. | |||||||
During the year ending December 28, 2013 the Company recorded amortization of the 2013A Notes debt discount in the amount of $94,030 which was included in interest expense. | |||||||
During the year ended December 28, 2013, the Company recorded $346,789 (2012: $59,642) in interest expense for the amortization of deferred issuance costs. |
Capital_Stock
Capital Stock | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Capital Stock [Text Block] | ' | ||||||
10 | Common Stock | ||||||
During the year ended December 28, 2013, the Company issued shares of common stock as follows: | |||||||
a) | The Company closed a private placement with a closing date of December 20, 2013 for 3,333,333 units for aggregate gross proceeds of $1,879,400 (CAD$2,000,000). Each unit is comprised of one common share and one common share purchase warrant of the Company. Each warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of CAD$0.70 per common share for a term of five years. The Company used the residual method to value the warrants and determined the value to be nominal. | ||||||
b) | The Company issued a total of 196,000 common shares pursuant to the exercise of employee and consultants’ options between the exercise prices of $0.87 and $1.17 per share for gross proceeds of $192,871. Of this amount, a total of 166,000 options with total proceed of $163,020 were exercised by the directors and officers of the Company. | ||||||
c) | The Company issued 37,500 common shares pursuant to the exercise of warrants with an exercise price of $1.25 per share for proceeds of $46,875. | ||||||
During the year ended December 31, 2012, the Company issued shares of common stock as follows: | |||||||
a) | The Company closed three tranches of a private placement with the last closing on October 10, 2012 for 1,067,774 units for aggregate gross proceeds of $2,359,780. Proceeds of $64,050 were included in subscription receivable as at December 31, 2012. This was subsequently written off during the year ended December 28, 2013. Each unit is comprised of one common share and one half of one common share purchase warrant of the Company. Each warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of $3.45 per common share for a term of two years. The fair value of the warrants was estimated to be $280,496 using the Black Scholes option pricing model, a 2 year term, an expected volatility of 66% to 67% and a risk free interest rate of 0.23% to 25%. The fair value of the warrants was recorded in the derivative liability as the warrants have an exercise price in a currency other than the Company’s functional currency. | ||||||
b) | The Company issued 821,299 common shares pursuant to the exercise of employee and consultants’ options between $0.87 and $2.77 per share for proceeds of $868,768, of this a total of 565,635 options for total proceeds of $608,376 were exercised by the directors and officers of the Company. | ||||||
c) | The Company issued 648,591 common shares pursuant to the exercise of warrants with an exercise price between $1.20 and $1.38 per share for proceeds of $859,285. | ||||||
Warrants | |||||||
Stock purchase warrants outstanding at December 28, 2013 are summarized as follows: | |||||||
Weighted Average | |||||||
Remaining | |||||||
Range of Exercise Prices | Number of Warrants | Contractual Life | |||||
$0.70 - $3.45 | 6,887,580 | 3.60 years | |||||
A summary of the Company’s stock purchase warrants are as follows: | |||||||
Weighted- | |||||||
Average | |||||||
Shares | Exercise Price | ||||||
Warrants outstanding at December 31, 2011 | 3,294,229 | 3.57 | |||||
Warrants granted during the year | 541,167 | 3.42 | |||||
Warrants expired during the year | (29,957 | ) | 1.38 | ||||
Warrants exercised during the year | (648,591 | ) | 1.32 | ||||
Warrants outstanding at December 31, 2012 | 3,156,848 | 4.02 | |||||
Warrants granted during the year | 6,353,963 | 0.96 | |||||
Warrants expired during the year | (2,585,731 | ) | 4.17 | ||||
Warrants exercised during the year | (37,500 | ) | 1.25 | ||||
Warrants outstanding at December 28, 2013 | 6,887,580 | 1.15 |
Stock_Options
Stock Options | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Stock Options [Text Block] | ' | ||||||
11. Stock Options | |||||||
Amended 2011 Fixed Share Option Plan | |||||||
On June 26, 2012, the board amended the Company’s 2011 Fixed Share Option Plan to increase the number of common shares reserved for the issuance under the Company’s 2011 Fixed Share Option Plan from 8,224,240 to 8,512,976 thereunder. On September 9, 2013, the board further amended the Company’s 2011 Fixed Share Option Plan to increase the number of common shares reserved for the issuance under the Company’s 2011 Fixed Share Option Plan from 8,512,976 to 8,894,539 thereunder and to remove the vesting schedule attached as Schedule “B” to the 2011 Fixed Share Option Plan. All other terms of the 2011 Fixed Share Option Plan will remain unchanged. | |||||||
The fair value of options issued during the years ended December 28, 2013 and 2012 were determined using the Black-Scholes option pricing model with the following assumptions: | |||||||
Year ended | Year ended | ||||||
28-Dec-13 | 31-Dec-12 | ||||||
Risk-free interest rates | 0.75% to 0.90% | 0.18% to 0.39% | |||||
Volatility factor | 63% to 66% | 74% to 75% | |||||
Expected life of options, in years | 4.2 | 4.17 | |||||
Weighted average fair value of options granted | $1.15 | $1.34 | |||||
During the year ended December 28, 2013, the Company granted a total of 285,000 (2012 – 1,849,500) common stock options to directors, officers, employees, eligible consultants, exercisable between $2.24 to $2.30 per share (2012 - $2.23 to $2.31), with a term of five years and an estimated fair value of $328,757 (2012 - $1,973,289). | |||||||
During the year ended December 28, 2013, 2,253,762 (2012 – 303,250) options vested. Total expense of $1,889,307 (2012 - $325,724) was recorded as stock-based compensation, $1,582,705 (2012 - $279,914) was charged to salaries and benefits expense and $306,602 (2012 - $45,810) was charged to consulting and contract labor expense. | |||||||
Original 2011 Fixed Share Option Plan | |||||||
In September 2011, the Company’s Board of Directors approved the 2011 Fixed Share Option Plan (the “2011 Plan”), a non-shareholder approved plan for grants of stock options to directors, officers, employees, eligible consultants of the Company and any related company. Based on the terms of the individual option grants, options granted under the 2011 Plan generally expire three to ten years after the grant date and become exercisable over a period of one year, based on continued employment, either with monthly vesting or upon achievement of predetermined deliverables. The 2011 Plan permits the granting of incentive stock options and nonqualified stock options up to an aggregate at any point in time of 8,224,240 shares. | |||||||
The fair value of options issued during the year ended December 31, 2012 was determined using the Black-Scholes option pricing model with the following assumptions: | |||||||
Year ended | |||||||
31-Dec-12 | |||||||
Risk-free interest rates | 0.78% to 0.92% | ||||||
Volatility factor | 88% to 89% | ||||||
Expected life of options, in years | 5 | ||||||
Weighted average fair value of options granted | $2.14 | ||||||
During the year ended December 28, 2013, the Company granted a total of nil (2012 - 125,000) common stock options to directors, officers, employees, eligible consultants, exercisable at $1.31 to $2.09 per share, with a term of five years with an estimated fair value of $nil (2012 - $210,136). | |||||||
During the year ended December 28, 2013, 25,000 (2012 – 85,423) options vested. Total expense of $38,273 (2012 – $210,275) was recorded as stock-based compensation and $38,273 (2012 – $210,275) was charged to salaries and benefits expense. | |||||||
2010 Fixed Share Option Plan | |||||||
In September 2010, the Company’s Board of Directors approved the 2010 Fixed Share Option Plan (the “2010 Plan”), a non-shareholder approved plan for grants of stock options to directors, officers, employees, eligible consultants of the Company and any related company. Based on the terms of the individual option grants, options granted under the 2010 Plan generally expire three to ten years after the grant date and become exercisable over a period of one year, based on continued employment, either with monthly vesting or upon achievement of predetermined deliverables. The 2010 Plan permits the granting of incentive stock options and nonqualified stock options up to an aggregate at any point in time of 7,057,640 shares. | |||||||
The fair value of options issued during the years ended December 31, 2012 were determined using the Black-Scholes option pricing model with the following assumptions: | |||||||
Year ended | |||||||
31-Dec-12 | |||||||
Risk-free interest rates | 0.90% to 0.1.56% | ||||||
Volatility factor | 68% to 91% | ||||||
Expected life of options, in years | 5 | ||||||
Weighted average fair value of options granted | $1.66 | ||||||
During the year ended December 28, 2013, 500,000 (2012 - 862,356) options vested. Total expense of $77,067 (2012 - $1,861,820) was recorded as stock-based compensation, $77,067 (2012 - $1,602,219) was included in salaries and benefits expense and $nil (2012 - $259,601) was included in consulting and labour expense. | |||||||
A summary of the Company’s stock options are as follows: | |||||||
Weighted-Average | |||||||
Shares | Exercise Price | ||||||
Options outstanding, December 31, 2011 | 5,281,945 | $ | 1.48 | ||||
Options exercised during the year | (821,229 | ) | 1.06 | ||||
Options granted during the year | 1,974,500 | 2.25 | |||||
Options cancelled during the year | (19,173 | ) | 1.93 | ||||
Options outstanding, December 31, 2012 | 6,416,043 | 1.77 | |||||
Options exercised during the year | (196,000 | ) | 0.98 | ||||
Options granted during the year | 285,000 | 2.25 | |||||
Options cancelled/expired during the year | (36,244 | ) | 2.09 | ||||
Options outstanding, December 28, 2013 | 6,468,799 | 1.81 | |||||
December 28, 2013 | |||||||
Options Outstanding | Options Exercisable | ||||||
Weighted | |||||||
Average | Weighted | Weighted | |||||
Range of | Remaining | Average | Average | ||||
Exercise | Number | Contractual | Exercise | Number | Exercise | ||
Prices | Outstanding | Life (yr.) | Price | Exercisable | Price | ||
$0.87 - $3.05 | 6,468,799 | 2.46 | $1.81 | 6,301,720 | $1.81 | ||
December 31, 2012 | |||||||
Options Outstanding | Options Exercisable | ||||||
Weighted | |||||||
Average | Weighted | Weighted | |||||
Range of | Remaining | Average | Average | ||||
Exercise | Number | Contractual | Exercise | Number | Exercise | ||
Prices | Outstanding | Life (yr.) | Price | Exercisable | Price | ||
$0.87 - $3.05 | 6,416,043 | 4.98 | $1.77 | 4,304,990 | $1.69 | ||
Business_Combination
Business Combination | 12 Months Ended | |||
Dec. 28, 2013 | ||||
Business Combination [Text Block] | ' | |||
12 | Business Combination | |||
On December 1, 2013 the Company acquired the assets of Schrurs NV, a textile company located in Ieper, Belgium, by means of an asset purchase agreement. The assets purchased include all of the production equipment, computer equipment and the rights to all of the employee contracts. The purchase price of the assets of Schrurs NV was settled by the Company assuming outstanding debt of $1,172,081 (€861,551). The general decline in the textile business in Europe had left assets available at a favorable price for the Company. This acquisition resulted in a bargain purchase gain of $425,909 as follows: | ||||
Fair value of assets acquired | $ | 1,797,121 | ||
Fair value of debt assumed | (1,172,081 | ) | ||
Deferred income tax liability | (199,131 | ) | ||
Bargain purchase gain | $ | 425,909 | ||
Under the terms of the asset purchase agreement, for a term of five years from the closing date of December 1, 2013, the repayment of the debt assumed by the Company shall be made in accordance with the terms of such debts and / or the repayment terms agreed upon between the seller and the respective creditors of the seller’s debts. On the fifth anniversary of the closing date, the aggregate outstanding amount under the seller’s debts at that point in time, shall be repaid in whole by the Company to the respective creditors of the seller’s debts. Between December 1, 2013 and December 28, 2013, no payments were made. | ||||
At December 28, 2013 the debt assumed consists of the following, including a foreign exchange effect of $13,596 : | ||||
Bank line of credit, bearing interest at 3.25%, repayable June 25, 2014 | $ | 313,088 | ||
Bank term loans, bearing interest ranging from 3.1% to 4.55%, repayable between | ||||
September 2014 and August 2022. | 712,881 | |||
Loan payable on demand bearing interest at 4% per annum | 90,897 | |||
Loan payable on demand bearing no interest | 68,810 | |||
1,185,676 | ||||
Less: current portion | 634,486 | |||
$ | 551,190 | |||
All of the above debt is denominated in Euros. |
Commitments
Commitments | 12 Months Ended | |||
Dec. 28, 2013 | ||||
Commitments [Text Block] | ' | |||
13 | Commitments | |||
a) Leases | ||||
The Company is committed to lease payments totaling approximately $1,930,000 for premises under lease. The minimum lease payments over the next five years are as follows: | ||||
2014 | $ | 296,579 | ||
2015 | 209,539 | |||
2016 | 209,539 | |||
2017 | 209,539 | |||
2018 | 209,539 | |||
Total | $ | 1,134,735 | ||
b) | National Research Council of Canada (“NRC”) | |||
Joint Collaboration Agreement | ||||
In October 2007, the Company entered into a joint collaboration agreement with the NRC to continue to develop a patentable enzyme technology for the processing of hemp fibers. The agreement was for three years and expired on May 9, 2010. On February 19, 2010, the Company signed an amendment to the agreement to extend expiry to May 9, 2012. The Company intends to continue its joint collaboration of enzyme technology with the NRC; however the research will refocus on cellulose technology for the production of lignocellulosic ethanol. The NRC is to be paid as it conducts work on the joint collaboration. There are no further costs or other off-balance sheet liabilities associated with the NRC agreement. | ||||
Technology License Agreement | ||||
On November 1, 2006, the Company entered into a technology license agreement with the NRC. The license agreement provides the Company a worldwide license to use and sublicense the NRC technology called CRAiLAR ® . The Company paid an initial $20,525 (CAD $25,000) fee and will pay an ongoing royalty of 3% on sales of products derived from the CRAiLAR ® process to the NRC with a minimum annual payment set at $14,750 (CAD$15,000) per year in two installments. During the year ended December 28, 2013 the Company paid $7,375 (CAD$7,500) and accrued $7,375 (CAD$7,500) of the minimum annual royalty. |
Income_Taxes
Income Taxes | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Income Taxes [Text Block] | ' | ||||||
14. Income Taxes | |||||||
As at December 28, 2013, the Company has estimated Canadian tax loss carry forwards for tax purposes of approximately $21,672,697 (2012 - $17,964,466) which expire between 2014 and 2033. Tax losses may be applied against future taxable income. Management has determined that the realization of the potential deferred tax assets resulting from these losses and other temporary differences is uncertain at this time, and cannot be viewed as more likely than not. Accordingly, the Company has recorded a full valuation allowance for the potential deferred tax asset. | |||||||
The reported income taxes differ from the amounts obtained by applying statutory rates to the loss before income taxes as follows: | |||||||
2013 | 2012 | ||||||
Loss before income taxes | $ | 15,169,933 | $ | 9,315,360 | |||
Combined Canadian and US corporate tax rate | 30.48% | 28.85% | |||||
Expected income tax recovery | (4,623,968 | ) | (2,654,878 | ) | |||
Increase (decrease) resulting from: | |||||||
Permanent differences and others | 255,649 | 468,899 | |||||
Change in valuation allowance | 5,155,729 | 2,324,647 | |||||
Impact of foreign exchange changes | (564,191 | ) | (101,609 | ) | |||
Impact of tax rate changes | (223,219 | ) | (37,059 | ) | |||
Future income tax expense | $ | - | $ | - | |||
The tax effects of temporary differences that give rise to the Company’s future tax asset (liability) are as follows: | |||||||
2013 | 2012 | ||||||
Property and equipment and intangible assets | $ | (168,845 | ) | $ | 89,513 | ||
Research and development costs | 999,811 | 806,068 | |||||
Share issue costs | 165,590 | 196,805 | |||||
Other finance costs | 1,883 | 124,546 | |||||
Loss carry forwards | 10,999,463 | 5,824,372 | |||||
11,997,902 | 7,041,304 | ||||||
Valuation allowance | (12,197,033 | ) | (7,041,304 | ) | |||
$ | (199,131 | ) | $ | - | |||
The Company’s non-capital losses expire as follows: | |||||||
Year of Expiry | Canada | USA | |||||
2014 | $ | 992,010 | $ | - | |||
2015 | 1,119,758 | - | |||||
2026 | 1,219,361 | - | |||||
2027 | 1,346,174 | - | |||||
2028 | 2,160,578 | - | |||||
2029 | 2,744,383 | - | |||||
2030 | 1,873,136 | 75,478 | |||||
2031 | 2,960,048 | 594,348 | |||||
2032 | 2,443,098 | 3,476,071 | |||||
2033 | 4,814,151 | 9,361,551 | |||||
$ | 21,672,697 | $ | 13,507,448 |
Related_Parties_Transactions
Related Parties Transactions | 12 Months Ended |
Dec. 28, 2013 | |
Related Parties Transactions [Text Block] | '15. Related Party Transactions |
During the year ended December 28, 2013, $1,513,412 (2012 - $1,410,203) was incurred as remuneration to officers and directors of the Company. Of this amount, $1,455,282 (2012 - $1,410,203) is recorded in salaries and benefits expense. | |
During the year ended December 28, 2013, $1,382,147 (2012 - $1,681,761) was recorded as stock-based compensation to officers and directors of the Company. Of this amount, $1,382,147 (2012 - $1,681,761) is recorded in salaries and benefits expense. | |
Refer to Note 8. |
Subsequent_Events
Subsequent Events | 12 Months Ended | |
Dec. 28, 2013 | ||
Subsequent Events [Text Block] | ' | |
16. Subsequent Events | ||
a) | On January 20, 2014, the TSX-V approved the Company’s proposal to issue 181,666 bonus shares at to Mr. Robert Edmunds in consideration of the CAD$545,000 convertible promissory note (Note 8). | |
b) | Subsequent to year end, the Company received $2,197,153 (€1,597,000) pursuant to a loan agreement entered into with IKEA Supply AG (“IKEA”) with an effective date of November 29, 2013. The loan bears an interest rate of 1.9% per annum and is payable in monthly installments of € 11,000 from December 20, 2014 through June 20, 2016 with the remainder due in full on June 25, 2016. IKEA agreed to loan the Company $3,028,300 (€2,190,000) leaving $831,147 (€593,000) as an unused credit facility. The loan is secured by assets purchased with the proceeds, as well as a portion of the secured assets used to secure the 2013A Notes. | |
c) | On March 20, 2014, the Company completed a private placement equity financing consisting of the sale of 2,515,000 units at $1.25 per unit for gross proceeds of $3,143,750. Each Unit is comprised of one common share and one-half of one transferable common share purchase warrant of the Company, and each whole warrant will entitle the holder thereof to purchase one additional common share of the Company at an exercise price of $1.75 per warrant share for a period of two years from closing, that is, until March 20, 2016. In addition, finders’ fees of an aggregate of 176,400 shares were issued to certain finders in conjunction with the closing of this private placement. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies (Policies) | 12 Months Ended | ||
Dec. 28, 2013 | |||
Cash and Cash Equivalents [Policy Text Block] | ' | ||
b) | Cash and Cash Equivalents | ||
Cash equivalents consist of cash on deposit and term deposits with original maturities of one year or less at the time of issuance. As at December 28, 2013, the Company held $15,000 (2012 - $20,000) in cash equivalents. | |||
Inventory [Policy Text Block] | ' | ||
c) | Inventory | ||
The raw flax fiber feedstock, decorticated fiber and Crailar fiber is valued at the lower of cost and market. All direct costs are capitalized to raw flax fiber inventory, decorticated fiber inventory and Crailar fiber. | |||
Seed inventory was valued at the lower of average cost and market. Cost comprised the cost to purchase seed and/or growing cost plus any related shipping costs. | |||
Other inventories, which consists of production consumables, are recorded at the lower of cost and replacement cost which approximates net realizable value. | |||
Use of Estimates [Policy Text Block] | ' | ||
d) | Use of Estimates | ||
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Significant areas requiring management’s estimates and assumptions are inventory costing and net realizable value, the expected future use and other impairment considerations of property and equipment, fair value of warrants, options, derivative liabilities, provision for income taxes, depreciation and financial instruments. | |||
Property and Equipment [Policy Text Block] | ' | ||
e) | Property and Equipment | ||
Property and equipment are stated at cost and are depreciated as follows: | |||
Automobiles | 20% declining balance | ||
Computer equipment | 30% declining balance | ||
Computer software | 100% declining balance | ||
Equipment | 30% declining balance | ||
Furniture and fixtures | 20% declining balance | ||
Production Equipment | 30% declining balance | ||
Leasehold improvements | Term of lease | ||
Website development | 100% declining balance | ||
Depreciation is claimed at one-half of the regular rate in the year of addition, no depreciation is claimed in the year of disposal. | |||
Intangible Assets [Policy Text Block] | ' | ||
f) | Intangible Assets | ||
Intangible assets are stated at cost and are amortized as follows: | |||
Trademarks | 5 year straight - line | ||
License Fee | 10 year straight - line | ||
Patent | 10 year straight – lin | ||
Revenue Recognition [Policy Text Block] | ' | ||
g) | Revenue Recognition | ||
Revenue is recognized when there is persuasive evidence of a sale arrangement, delivery to the customer has occurred, the fee is fixed and determinable, and collectability is considered probable. | |||
Foreign Currency Translation [Policy Text Block] | ' | ||
h) | Foreign Currency Translation | ||
The Company’s functional currency is Canadian dollars. The Company translates its financial statements to U.S. dollars using the following method: | |||
All assets and liabilities are translated into U.S. dollars at the exchange rate in effect at the year-end. Revenues and expenses are translated throughout the year at the weighted average exchange rate. Exchange gains or losses from such translations are included in accumulated comprehensive income (loss), as a separate component of stockholders’ equity. | |||
Foreign currency transaction gains and losses are included in the statement of operations and comprehensive loss. | |||
Income Taxes [Policy Text Block] | ' | ||
i) Income Taxes | |||
The Company utilizes the liability method of accounting for deferred income taxes. Under the liability method, deferred income taxes are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates. A valuation allowance is recorded when it is more likely than not that potential the future tax assets will not be realized. | |||
Comprehensive Loss [Policy Text Block] | ' | ||
j) Comprehensive Loss | |||
Comprehensive loss is the change in equity during a period resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Other comprehensive income (loss) comprises items of income and expenses that are not recognized in net loss as required or permitted by GAAP. | |||
Stock-based Compensation [Policy Text Block] | ' | ||
k) Stock-based Compensation | |||
The Company accounts for stock-based payment transactions in which an enterprise receives services in exchange for (a) equity instruments of the enterprise or (b) liabilities that are based on the fair value of the enterprise’s equity instruments or that may be settled by the issuance of such equity instruments. The Company uses the Black-Scholes option-pricing model to establish the fair-value of stock-based awards. | |||
Earnings (Loss) Per Share [Policy Text Block] | ' | ||
l) Earnings (Loss) Per Share | |||
Basic and diluted earnings (loss) per share are computed using the weighted average number of shares outstanding during the year. Common stock equivalents from stock options and warrants were excluded from the calculation of net loss per share for the years ended December 28, 2013 and December 31, 2012 as their effect is anti-dilutive. | |||
Long-Lived Asset Impairment [Policy Text Block] | ' | ||
m) Long-Lived Asset Impairment | |||
Long-lived assets of the Company are reviewed when changes in circumstances suggest their carrying value has become impaired. Management considers assets to be impaired if the carrying value exceeds the estimated discounted future projected cash flows to result from the use of the asset and its eventual disposition. If impairment is deemed to exist, the assets will be written down to fair value. Fair value is generally determined using a hierarchy of fair value methodologies under GAAP, primarily based on a discounted cash flow analysis. | |||
Risk Management [Policy Text Block] | ' | ||
n) Risk Management | |||
Currency risk. The Company is exposed to currency risk to the extent that certain inventory and equipment is purchased from Europe. The purchase price for such inventory and equipment is generally in Euros. The Company does not currently hedge its foreign currency exposure, and accordingly, is at risk for foreign currency exchange fluctuations. The Company and its subsidiaries do not have significant transactions or hold significant cash denominated in currencies other than their functional currencies. | |||
Credit risk. The risk in cash accounts is managed through the use of a major financial institution, which has high credit quality as determined by the rating agencies. As at December 28, 2013, $158,000 is due from a single customer and therefore 61% of receivables are exposed to concentration of credit risk. | |||
Interest rate risk. Approximately $1,026,000 of the Company’s debt bears interest at fluctuating rates. Consequentially the Company is exposed to interest rate fluctuations. The Company does not currently hedge its exposure to interest rate risk. | |||
Commodity price risk. Commodity price risk is the risk that the fair value of future cash flows will fluctuate because of changes in the market prices of commodities. The Company is exposed to commodity price risk as it purchases fiber feedstock from the flax producers in Europe. The Company purchases the short fiber waste product called “tow” and the price fluctuates based on supply. The Company has relationships with several short fiber producers and anticipates little issue in obtaining sufficient fiber for its needs. The Company does not currently enter into futures contracts or otherwise hedge its exposure to commodity price risk. | |||
Research and Development [Policy Text Block] | ' | ||
o) Research and Development | |||
Research and development costs are charged to operations as incurred. | |||
Recent Pronouncements [Policy Text Block] | ' | ||
p) Recent Pronouncements There are no recent pronouncements that are applicable to the Company. |
Significant_Accounting_Policie1
Significant Accounting Policies (Tables) | 12 Months Ended | ||
Dec. 28, 2013 | |||
Schedule of Property, Plant and Equipment, Declining Balances [Table Text Block] | ' | ||
Automobiles | 20% declining balance | ||
Computer equipment | 30% declining balance | ||
Computer software | 100% declining balance | ||
Equipment | 30% declining balance | ||
Furniture and fixtures | 20% declining balance | ||
Production Equipment | 30% declining balance | ||
Leasehold improvements | Term of lease | ||
Website development | 100% declining balance | ||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | ' | ||
Trademarks | 5 year straight - line | ||
License Fee | 10 year straight - line | ||
Patent | 10 year straight – lin |
Inventory_Tables
Inventory (Tables) | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Schedule of Inventory, Current [Table Text Block] | ' | ||||||
28-Dec-13 | 31-Dec-12 | ||||||
CRAiLAR fiber | $ | 186,464 | $ | - | |||
Decorticated fiber | 252,263 | 51,504 | |||||
Flax seed | - | 1,172,155 | |||||
Raw flax fiber feedstock | 369,590 | 1,680,993 | |||||
Other | 136,723 | - | |||||
$ | 945,040 | $ | 2,904,652 | ||||
Schedule of Inventory Write-downs [Table Text Block] | ' | ||||||
28-Dec-13 | 31-Dec-12 | ||||||
CRAiLAR fiber | $ | 274,297 | $ | - | |||
Decorticated fiber | 196,861 | - | |||||
Flax seed | 1,891,217 | 303,663 | |||||
Raw flax fiber feedstock | 2,279,887 | - | |||||
$ | 4,642,262 | $ | 303,663 |
Property_and_Equipment_Tables
Property and Equipment (Tables) | 12 Months Ended | ||||||||||||
Dec. 28, 2013 | |||||||||||||
Property, Plant and Equipment [Table Text Block] | ' | ||||||||||||
Net Book Value | Net Book Value | ||||||||||||
Accumulated | December 28, | December 31, | |||||||||||
Cost | Depreciation | 2013 | 2012 | ||||||||||
Automobiles | $ | 58,743 | $ | 8,876 | $ | 49,867 | $ | 57,559 | |||||
Computer equipment | 126,192 | 69,019 | 57,180 | 48,398 | |||||||||
Equipment | 754,902 | 98,556 | 656,346 | 359,445 | |||||||||
Equipment held for sale | 70,000 | - | 70,000 | 105,045 | |||||||||
Furniture and fixtures | 62,339 | 36,918 | 25,421 | 29,980 | |||||||||
Leasehold improvements | 6,327,333 | 615,459 | 5,498,633 | 4,979,548 | |||||||||
Production equipment | 5,095,961 | 277,681 | 4,818,280 | - | |||||||||
Production equipment in construction | 6,060,849 | - | 6,060,849 | 7,606,837 | |||||||||
Website development costs | 121,330 | 117,365 | 3,436 | 61,876 | |||||||||
$ | 18,464,408 | $ | 1,224,396 | $ | 17,240,012 | $ | 13,248,688 |
Intangible_Assets_Tables
Intangible Assets (Tables) | 12 Months Ended | ||||||||||||
Dec. 28, 2013 | |||||||||||||
Schedule of Intangible Assets and Goodwill [Table Text Block] | ' | ||||||||||||
Accumulated | Net Book Value | Net Book Value | |||||||||||
Cost | Amortization | 28-Dec-13 | 31-Dec-12 | ||||||||||
Patents | $ | 158,367 | $ | 72,885 | $ | 85,482 | $ | 77,961 | |||||
Trademarks | 121,968 | 93,903 | 28,065 | 7,639 | |||||||||
License fee | 62,710 | 20,712 | 41,998 | 9,019 | |||||||||
$ | 343,045 | $ | 187,500 | $ | 155,545 | $ | 94,619 |
Derivative_liability_Tables
Derivative liability (Tables) | 12 Months Ended | |||||||||
Dec. 28, 2013 | ||||||||||
Schedule of Derivative Instruments [Table Text Block] | ' | |||||||||
December 28, | December 31, | |||||||||
Exercise price | 2013 | 2012 | ||||||||
275,506 warrants expired on May 19, 2013 | US$1.25 | $ | - | $ | 257,564 | |||||
533,887 warrants expiring on Oct 14, 2014 | US$3.45 | - | 230,471 | |||||||
$ | - | $ | 488,035 | |||||||
Schedule of Derivative Instruments, Valuation Assumptions [Table Text Block] | ' | |||||||||
28-Dec-13 | 31-Dec-12 | |||||||||
Volatility | 60% | 57% - 83% | ||||||||
Dividend yield | - | - | ||||||||
Risk-free interest rate | 0.09% | 0.14 – 0.72% | ||||||||
Expected life | 0.62 years | 0.38 – 1.18 yrs. |
Notes_Payable_Tables
Notes Payable (Tables) | 12 Months Ended | |||
Dec. 28, 2013 | ||||
Convertible Note Payable [Table Text Block] | ' | |||
28-Dec-13 | ||||
Principal | $ | 669,335 | ||
Interest | 23,781 | |||
Repayment | (47,885 | ) | ||
Beneficial conversion feature | (188,140 | ) | ||
Accretion expense | 33,495 | |||
Effect of foreign exchange | (13,872 | ) | ||
$ | 476,614 |
Long_term_debt_Tables
Long term debt (Tables) | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Schedule of Long-term Debt Instruments [Table Text Block] | ' | ||||||
28-Dec-13 | 31-Dec-12 | ||||||
Balance, beginning | $ | 10,051,262 | $ | - | |||
Convertible debenture issued | 8,307,249 | 10,051,262 | |||||
Discount on debentures | (754,829 | ) | - | ||||
Amendment of debentures – conversion price | (79,931 | ) | - | ||||
Accretion expense | 94,030 | - | |||||
Effect of foreign exchange | (943,095 | ) | - | ||||
Balance, ending | $ | 16,674,686 | $ | 10,051,262 | |||
Schedule of Deferred debt issuance costs [Table Text Block] | ' | ||||||
28-Dec-13 | 31-Dec-12 | ||||||
Balance, beginning | $ | 1,024,294 | $ | - | |||
Issuance costs – cash | 886,733 | 1,083,936 | |||||
Issuance costs – warrants | 66,278 | - | |||||
Issuance costs allocated to additional paid in capital | (102,670 | ) | - | ||||
Amortization of issuance costs | (346,789 | ) | (59,642 | ) | |||
Effect of foreign exchange | (85,823 | ) | - | ||||
$ | 1,442,023 | $ | 1,024,294 |
Capital_Stock_Tables
Capital Stock (Tables) | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | ' | ||||||
Weighted Average | |||||||
Remaining | |||||||
Range of Exercise Prices | Number of Warrants | Contractual Life | |||||
$0.70 - $3.45 | 6,887,580 | 3.60 years | |||||
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block] | ' | ||||||
Weighted- | |||||||
Average | |||||||
Shares | Exercise Price | ||||||
Warrants outstanding at December 31, 2011 | 3,294,229 | 3.57 | |||||
Warrants granted during the year | 541,167 | 3.42 | |||||
Warrants expired during the year | (29,957 | ) | 1.38 | ||||
Warrants exercised during the year | (648,591 | ) | 1.32 | ||||
Warrants outstanding at December 31, 2012 | 3,156,848 | 4.02 | |||||
Warrants granted during the year | 6,353,963 | 0.96 | |||||
Warrants expired during the year | (2,585,731 | ) | 4.17 | ||||
Warrants exercised during the year | (37,500 | ) | 1.25 | ||||
Warrants outstanding at December 28, 2013 | 6,887,580 | 1.15 |
Stock_Options_Tables
Stock Options (Tables) | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | ' | ||||||
Weighted-Average | |||||||
Shares | Exercise Price | ||||||
Options outstanding, December 31, 2011 | 5,281,945 | $ | 1.48 | ||||
Options exercised during the year | (821,229 | ) | 1.06 | ||||
Options granted during the year | 1,974,500 | 2.25 | |||||
Options cancelled during the year | (19,173 | ) | 1.93 | ||||
Options outstanding, December 31, 2012 | 6,416,043 | 1.77 | |||||
Options exercised during the year | (196,000 | ) | 0.98 | ||||
Options granted during the year | 285,000 | 2.25 | |||||
Options cancelled/expired during the year | (36,244 | ) | 2.09 | ||||
Options outstanding, December 28, 2013 | 6,468,799 | 1.81 | |||||
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] | ' | ||||||
December 28, 2013 | |||||||
Options Outstanding | Options Exercisable | ||||||
Weighted | |||||||
Average | Weighted | Weighted | |||||
Range of | Remaining | Average | Average | ||||
Exercise | Number | Contractual | Exercise | Number | Exercise | ||
Prices | Outstanding | Life (yr.) | Price | Exercisable | Price | ||
$0.87 - $3.05 | 6,468,799 | 2.46 | $1.81 | 6,301,720 | $1.81 | ||
December 31, 2012 | |||||||
Options Outstanding | Options Exercisable | ||||||
Weighted | |||||||
Average | Weighted | Weighted | |||||
Range of | Remaining | Average | Average | ||||
Exercise | Number | Contractual | Exercise | Number | Exercise | ||
Prices | Outstanding | Life (yr.) | Price | Exercisable | Price | ||
$0.87 - $3.05 | 6,416,043 | 4.98 | $1.77 | 4,304,990 | $1.69 | ||
Original 2011 Fixed Share Option Plan [Member] | ' | ||||||
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | ' | ||||||
Year ended | |||||||
31-Dec-12 | |||||||
Risk-free interest rates | 0.78% to 0.92% | ||||||
Volatility factor | 88% to 89% | ||||||
Expected life of options, in years | 5 | ||||||
Weighted average fair value of options granted | $2.14 | ||||||
Amended 2011 Fixed Share Option Plan [Member] | ' | ||||||
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | ' | ||||||
Year ended | Year ended | ||||||
28-Dec-13 | 31-Dec-12 | ||||||
Risk-free interest rates | 0.75% to 0.90% | 0.18% to 0.39% | |||||
Volatility factor | 63% to 66% | 74% to 75% | |||||
Expected life of options, in years | 4.2 | 4.17 | |||||
Weighted average fair value of options granted | $1.15 | $1.34 | |||||
2010 Fixed Share Option Plan [Member] | ' | ||||||
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | ' | ||||||
Year ended | |||||||
31-Dec-12 | |||||||
Risk-free interest rates | 0.90% to 0.1.56% | ||||||
Volatility factor | 68% to 91% | ||||||
Expected life of options, in years | 5 | ||||||
Weighted average fair value of options granted | $1.66 |
Business_Combination_Tables
Business Combination (Tables) | 12 Months Ended | |||
Dec. 28, 2013 | ||||
Business Combination, Segment Allocation [Table Text Block] | ' | |||
Fair value of assets acquired | $ | 1,797,121 | ||
Fair value of debt assumed | (1,172,081 | ) | ||
Deferred income tax liability | (199,131 | ) | ||
Bargain purchase gain | $ | 425,909 | ||
Business Combination, Separately Recognized Transactions [Table Text Block] | ' | |||
Bank line of credit, bearing interest at 3.25%, repayable June 25, 2014 | $ | 313,088 | ||
Bank term loans, bearing interest ranging from 3.1% to 4.55%, repayable between | ||||
September 2014 and August 2022. | 712,881 | |||
Loan payable on demand bearing interest at 4% per annum | 90,897 | |||
Loan payable on demand bearing no interest | 68,810 | |||
1,185,676 | ||||
Less: current portion | 634,486 | |||
$ | 551,190 |
Commitments_Tables
Commitments (Tables) | 12 Months Ended | |||
Dec. 28, 2013 | ||||
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] | ' | |||
2014 | $ | 296,579 | ||
2015 | 209,539 | |||
2016 | 209,539 | |||
2017 | 209,539 | |||
2018 | 209,539 | |||
Total | $ | 1,134,735 |
Income_Taxes_Tables
Income Taxes (Tables) | 12 Months Ended | ||||||
Dec. 28, 2013 | |||||||
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] | ' | ||||||
2013 | 2012 | ||||||
Loss before income taxes | $ | 15,169,933 | $ | 9,315,360 | |||
Combined Canadian and US corporate tax rate | 30.48% | 28.85% | |||||
Expected income tax recovery | (4,623,968 | ) | (2,654,878 | ) | |||
Increase (decrease) resulting from: | |||||||
Permanent differences and others | 255,649 | 468,899 | |||||
Change in valuation allowance | 5,155,729 | 2,324,647 | |||||
Impact of foreign exchange changes | (564,191 | ) | (101,609 | ) | |||
Impact of tax rate changes | (223,219 | ) | (37,059 | ) | |||
Future income tax expense | $ | - | $ | - | |||
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | ' | ||||||
2013 | 2012 | ||||||
Property and equipment and intangible assets | $ | (168,845 | ) | $ | 89,513 | ||
Research and development costs | 999,811 | 806,068 | |||||
Share issue costs | 165,590 | 196,805 | |||||
Other finance costs | 1,883 | 124,546 | |||||
Loss carry forwards | 10,999,463 | 5,824,372 | |||||
11,997,902 | 7,041,304 | ||||||
Valuation allowance | (12,197,033 | ) | (7,041,304 | ) | |||
$ | (199,131 | ) | $ | - | |||
Summary of Operating Loss Carryforwards [Table Text Block] | ' | ||||||
Year of Expiry | Canada | USA | |||||
2014 | $ | 992,010 | $ | - | |||
2015 | 1,119,758 | - | |||||
2026 | 1,219,361 | - | |||||
2027 | 1,346,174 | - | |||||
2028 | 2,160,578 | - | |||||
2029 | 2,744,383 | - | |||||
2030 | 1,873,136 | 75,478 | |||||
2031 | 2,960,048 | 594,348 | |||||
2032 | 2,443,098 | 3,476,071 | |||||
2033 | 4,814,151 | 9,361,551 | |||||
$ | 21,672,697 | $ | 13,507,448 |
Nature_of_Operations_and_Basis1
Nature of Operations and Basis of Presentation (Narrative) (Details) (USD $) | 12 Months Ended |
Dec. 28, 2013 | |
Cumulative Deficit | $47,422,847 |
Proceeds from (Payments for) Other Financing Activities | $2,119,146 |
Significant_Accounting_Policie2
Significant Accounting Policies (Narrative) (Details) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Cash Equivalents, at Carrying Value | $15,000 | $20,000 |
Credit risk, amount at risk | 158,000 | ' |
Credit risk, percentage at risk | 61.00% | ' |
Interest risk, amount at risk | $1,026,000 | ' |
Derivative_liability_Narrative
Derivative liability (Narrative) (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Class of Warrant or Right, Exercises in Period | 37,500 | 648,591 |
Adjustments to additional paid in capital, derivative liability | $35,190 | ' |
Notes_Payable_Narrative_Detail
Notes Payable (Narrative) (Details) | 12 Months Ended | 51 Months Ended | 12 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | ||||||||||||||
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2011 | Dec. 28, 2013 | Dec. 28, 2013 | Oct. 31, 2013 | Oct. 31, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Oct. 31, 2013 | Oct. 31, 2013 | Nov. 30, 2013 | Nov. 30, 2013 | Oct. 31, 2013 | Oct. 31, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Oct. 31, 2013 | Dec. 28, 2013 | |
USD ($) | USD ($) | USD ($) | USD ($) | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Mr. Robert Edmunds [Member] | Mr. Robert Edmunds [Member] | Mr. Robert Edmunds [Member] | Mr. Robert Edmunds [Member] | Mr. Robert Edmunds - 2 [Member] | Mr. Robert Edmunds - 2 [Member] | Mr. Jason Finnis [Member] | Mr. Jason Finnis [Member] | Mr. Jason Finnis [Member] | Mr. Jason Finnis [Member] | Mr. Jason Finnis [Member] | Mr. Jason Finnis [Member] | Mr. Kenneth Barker [Member] | Mr. Kenneth Barker [Member] | |
USD ($) | CAD | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | Convertible Promissory Notes [Member] | |||||
USD ($) | CAD | USD ($) | CAD | USD ($) | CAD | USD ($) | CAD | USD ($) | CAD | USD ($) | CAD | USD ($) | USD ($) | |||||||
Convertible debenture issued | $8,307,249 | $10,051,262 | ' | ' | ' | ' | $467,369 | 500,000 | ' | ' | $42,255 | 45,000 | ' | ' | $96,180 | 100,000 | ' | ' | $50,000 | ' |
Debt Instrument, Interest Rate, Stated Percentage | ' | ' | ' | ' | ' | ' | 20.00% | 20.00% | ' | ' | ' | ' | ' | ' | 12.00% | 12.00% | ' | ' | 12.00% | ' |
Bonus common shares issued | ' | ' | ' | ' | ' | ' | 181,666 | 181,666 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Accrued Interest | ' | ' | ' | ' | ' | ' | ' | ' | 20,896 | 22,667 | ' | ' | ' | ' | ' | ' | 1,210 | 1,290 | ' | 1,234 |
Convertible Debt, Current | ' | ' | ' | ' | ' | ' | ' | ' | 532,576 | 567,267 | ' | ' | ' | ' | ' | ' | 48,132 | 51,290 | ' | 51,234 |
Repayments of Convertible Debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 48,326 | 50,000 | ' | ' | ' | ' | ' | ' |
Interest Paid | 1,347,905 | 9,435 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 441 | 460 | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Conversion Price | ' | ' | ' | ' | $0.60 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price | $1.15 | $4.02 | $1.15 | $3.57 | $0.70 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Weighted Average Remaining Contractual Term | ' | ' | ' | ' | '5 years | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Beneficial Conversion Feature | 188,140 | ' | ' | ' | 188,140 | 200,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Accretion expense | 33,495 | ' | 33,495 | ' | 33,495 | 34,483 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Beneficial Conversion Feature, After Accretion | ' | ' | ' | ' | $154,645 | 165,517 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Long_term_debt_Narrative_Detai
Long term debt (Narrative) (Details) | 1 Months Ended | 12 Months Ended | 51 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||
Dec. 28, 2013 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Jul. 26, 2013 | Dec. 28, 2013 | |
CAD | USD ($) | USD ($) | USD ($) | Warrants [Member] | Warrants [Member] | Convertible Notes [Member] | Convertible Notes [Member] | Convertible Notes - 2012 [Member] | Convertible Notes - 2012 [Member] | Convertible Notes - 2012 [Member] | Convertible Notes - 2012 [Member] | Convertible Notes - 2013 [Member] | Convertible Notes - 2013 [Member] | Convertible Notes - 2013 [Member] | Convertible Notes - 2013 [Member] | Guaranty and Security Agreement - amendment [Member] | Closing a subordinated convertible debenture [Member] | Closing a subordinated convertible debenture [Member] | Closing a subordinated convertible debenture [Member] | Closing a subordinated convertible debenture [Member] | Closing a subordinated convertible debenture [Member] | Closing a subordinated convertible debenture [Member] | Closing a subordinated convertible debenture [Member] | Naturally Advanced Technologies [Member] | |
USD ($) | CAD | USD ($) | CAD | USD ($) | CAD | USD ($) | CAD | Agent warrants [Member] | Brokers Warrants [Member] | USD ($) | USD ($) | CAD | Warrants [Member] | Warrants [Member] | Convertible Notes - 2013 [Member] | Convertible Notes - 2013 [Member] | Convertible Notes - 2013 [Member] | USD ($) | |||||||
USD ($) | USD ($) | USD ($) | CAD | USD ($) | CAD | CAD | |||||||||||||||||||
Notes Issued | ' | ' | ' | ' | ' | ' | ' | ' | $10,051,262 | 10,000,000 | ' | ' | $4,943,643 | 5,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Interest Rate, Stated Percentage | ' | ' | ' | ' | ' | ' | ' | ' | 10.00% | 10.00% | ' | ' | 10.00% | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10.00% | ' |
Interest Payable | ' | ' | ' | ' | ' | ' | ' | ' | 277,513 | 277,397 | 264,143 | 281,471 | 114,412 | 121,918 | ' | ' | ' | ' | ' | ' | ' | 80,893 | 86,200 | ' | ' |
Payments of deferred debt issuance costs | ' | 886,733 | 1,083,936 | ' | ' | ' | ' | ' | 1,083,936 | 1,019,069 | ' | ' | 427,049 | 487,830 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instrument, Convertible, Conversion Price | ' | ' | ' | ' | ' | ' | $2.85 | 2.9 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1.25 | ' |
Business Acquisition, Cost of Acquired Entity, Purchase Price | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,922,240 | ' | ' | ' | ' | ' | ' | ' | 5,500,000 |
Deferred financing costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 337,469 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Convertible Debt | ' | 8,307,249 | 10,051,262 | 18,358,511 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,363,606 | 3,535,000 | ' | ' |
Class of Warrant or Right, Grants in Period, Net of Forfeitures | ' | 6,353,963 | 541,167 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 192,360 | ' | ' | 2,828,000 | 2,828,000 | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Grants in Period, Exercise Price | 0.7 | ' | $3.45 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.25 | $1.25 | $2 | ' | ' | ' | ' | ' | ' | ' |
Warrants Issued During Period, Value | ' | ' | 280,496 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 66,278 | ' | 79,931 | 974,387 | 1,003,910 | 754,829 | 777,700 | 2,295,309 | 2,757,300 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | ' | ' | ' | ' | 0.00% | 0.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.00% | 0.00% | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | ' | ' | ' | ' | 60.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 56.00% | 56.00% | 56.00% | 56.00% | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | ' | ' | ' | ' | 0.09% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.59% | 0.59% | 0.59% | 0.59% | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | ' | ' | ' | ' | '0 years 7 months 13 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '2 years 9 months 29 days | '2 years 5 months 1 day | '2 years 9 months 29 days | '2 years 9 months 29 days | ' | ' | ' | ' | ' | ' |
Amortization of debt discount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 94,030 | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred Issuance costs for convertible debenture | ' | 886,733 | 1,083,936 | 1,970,669 | ' | ' | ' | ' | ' | ' | ' | ' | 373,861 | ' | 440,139 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Additional Paid-in Capital | ' | 9,934,322 | 7,061,406 | 9,934,322 | ' | ' | ' | ' | ' | ' | ' | ' | 102,670 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Amortization of deferred debt issuance costs | ' | $346,789 | $59,642 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Capital_Stock_Narrative_Detail
Capital Stock (Narrative) (Details) | 1 Months Ended | 12 Months Ended | |||||||||||||||
Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 31, 2012 | |
USD ($) | CAD | USD ($) | USD ($) | Minimum [Member] | Minimum [Member] | Maximum [Member] | Maximum [Member] | Officers and directors [Member] | Officers and directors [Member] | Options for Employees and Consultants [Member] | Options for Employees and Consultants [Member] | Options for Employees and Consultants [Member] | Options for Employees and Consultants [Member] | Other Warrants [Member] | Other Warrants [Member] | Other Warrants [Member] | |
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Minimum [Member] | Maximum [Member] | USD ($) | Minimum [Member] | Maximum [Member] | |||||||
USD ($) | USD ($) | USD ($) | USD ($) | ||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | ' | ' | 196,000 | 821,229 | ' | ' | ' | ' | 166,000 | 565,635 | 196,000 | 821,299 | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | ' | ' | $0.98 | $1.06 | $0.87 | ' | $1.17 | ' | ' | ' | ' | ' | $0.87 | $2.77 | ' | ' | ' |
Proceeds from Stock Options Exercised | ' | ' | ' | ' | ' | ' | ' | ' | $163,020 | $608,376 | $192,871 | $868,768 | ' | ' | ' | ' | ' |
Class of Warrant or Right, Exercises in Period | ' | ' | 37,500 | 648,591 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 648,591 | ' | ' |
Class of Warrant or Right, Exercises in Period, Exercise Price | ' | ' | $1.25 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.20 | $1.38 |
Proceeds from Warrant Exercises | ' | ' | 46,875 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 859,285 | ' | ' |
Units Issued During Period, Units | 3,333,333 | 3,333,333 | ' | 1,067,774 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Units Issued During Period, Value | ' | ' | ' | 2,359,780 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from Units Issued During Period | 1,879,400 | 2,000,000 | ' | 64,050 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Units Issued During Period, Underlying Shares | 1 | 1 | ' | 1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Units Issued During Period, Underlying Warrants | 0.5 | 0.5 | ' | 0.5 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Grants in Period, Exercise Price | ' | 0.7 | ' | $3.45 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right, Grants in Period, Contractual Term | '5 years | '5 years | ' | '2 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Warrants Issued During Period, Value | ' | ' | ' | $280,496 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate | ' | ' | ' | ' | ' | 66.00% | ' | 67.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate | ' | ' | ' | ' | ' | 0.23% | ' | 25.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock_Options_Narrative_Detail
Stock Options (Narrative) (Details) (USD $) | 12 Months Ended | 51 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 31, 2012 | Jun. 26, 2012 | Sep. 30, 2011 | Dec. 28, 2013 | Dec. 31, 2012 | Sep. 09, 2013 | Sep. 08, 2013 | Jun. 26, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | Sep. 30, 2010 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 31, 2012 | |
Original 2011 Fixed Share Option Plan [Member] | Original 2011 Fixed Share Option Plan [Member] | Original 2011 Fixed Share Option Plan [Member] | Original 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | Amended 2011 Fixed Share Option Plan [Member] | 2010 Fixed Share Option Plan [Member] | 2010 Fixed Share Option Plan [Member] | 2010 Fixed Share Option Plan [Member] | 2010 Fixed Share Option Plan [Member] | 2010 Fixed Share Option Plan [Member] | 2010 Fixed Share Option Plan [Member] | 2010 Fixed Share Option Plan [Member] | |||||
Consulting and contract labour [Member] | Consulting and contract labour [Member] | Salaries and benefits [Member] | Salaries and benefits [Member] | Consulting and contract labour [Member] | Consulting and contract labour [Member] | Salaries and benefits [Member] | Salaries and benefits [Member] | |||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning of Period | 6,416,043 | 5,281,945 | ' | 6,468,799 | ' | ' | 8,224,240 | 8,224,240 | ' | ' | 8,894,539 | 8,512,976 | 8,512,976 | ' | ' | ' | ' | ' | ' | 7,057,640 | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 285,000 | 1,974,500 | ' | ' | 0 | 125,000 | ' | ' | 285,000 | 1,849,500 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit | $0.87 | $0.87 | ' | ' | $1.31 | ' | ' | ' | $2.24 | $2.23 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit | $3.05 | $3.05 | ' | ' | $2.09 | ' | ' | ' | $2.30 | $2.31 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $2.25 | $2.25 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value | ' | ' | ' | ' | $0 | $210,136 | ' | ' | $328,757 | $1,973,289 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period | ' | ' | ' | ' | 25,000 | 85,423 | ' | ' | 2,253,762 | 303,250 | ' | ' | ' | ' | ' | ' | ' | 500,000 | 862,356 | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 196,000 | 821,229 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation | $2,004,647 | $2,397,819 | $8,142,956 | ' | $38,273 | $210,275 | ' | ' | $1,889,307 | $325,724 | ' | ' | ' | $306,602 | $45,810 | $1,582,705 | $279,914 | $77,067 | $1,861,820 | ' | $0 | $259,601 | $77,067 | $1,602,219 |
Business_Combination_Narrative
Business Combination (Narrative) (Details) | 12 Months Ended | 51 Months Ended | |||
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 01, 2013 | Dec. 01, 2013 | |
USD ($) | USD ($) | USD ($) | USD ($) | EUR (€) | |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities | ' | ' | ' | $1,172,081 | € 861,551 |
Bargain purchase | 425,909 | 0 | 425,909 | ' | ' |
Business Combination, Liabilities Assumed, Foreign Exchange Effect | $13,596 | ' | ' | ' | ' |
Commitments_Narrative_Details
Commitments (Narrative) (Details) | 12 Months Ended | ||
Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | |
Lease for industrial and office building [Member] | NRC Technology License Agreement [Member] | NRC Technology License Agreement [Member] | |
USD ($) | USD ($) | CAD | |
Long-term Purchase Commitment, Amount | $1,930,000 | $14,750 | 15,000 |
Payments of Commitments | ' | 20,525 | 25,000 |
Royalty Percentage | ' | 3 | ' |
Royalty Expense | ' | $7,375 | 7,500 |
Income_Taxes_Narrative_Details
Income Taxes (Narrative) (Details) (Canada [Member], USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Canada [Member] | ' | ' |
Operating Loss Carryforwards | $21,672,697 | $17,964,466 |
Related_Parties_Transactions_N
Related Parties Transactions (Narrative) (Details) (USD $) | 12 Months Ended | 51 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | |
Share-based Compensation | $2,004,647 | $2,397,819 | $8,142,956 |
Officers and directors [Member] | ' | ' | ' |
Related Party Transaction, Amounts of Transaction | 1,513,412 | 1,410,203 | ' |
Share-based Compensation | 1,382,147 | 1,681,761 | ' |
Officers and directors [Member] | Salaries and benefits [Member] | ' | ' | ' |
Related Party Transaction, Amounts of Transaction | 1,455,282 | 1,410,203 | ' |
Share-based Compensation | $1,382,147 | $1,681,761 | ' |
Subsequent_Events_Narrative_De
Subsequent Events (Narrative) (Details) | 1 Months Ended | 12 Months Ended | 51 Months Ended | 12 Months Ended | ||||
Dec. 28, 2013 | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | Dec. 28, 2013 | |
CAD | USD ($) | USD ($) | USD ($) | Demand convertible promissory note in favor of Mr. Robert Edmunds (after period end) [Member] | Acquisition of a European facility (after period end) [Member] | Acquisition of a European facility (after period end) [Member] | Private Placement Equity Financing (after period end) [Member] | |
USD ($) | USD ($) | EUR (€) | USD ($) | |||||
Bonus common shares issued | ' | ' | ' | ' | 181,666 | ' | ' | ' |
Proceeds from Convertible Debt | ' | $8,307,249 | $10,051,262 | $18,358,511 | $545,000 | ' | ' | ' |
Notes Issued | ' | ' | ' | ' | ' | 2,197,153 | 1,597,000 | ' |
Debt Instrument, Interest Rate, Stated Percentage | ' | ' | ' | ' | ' | 1.90% | 1.90% | ' |
Debt Instrument, Periodic Payment | ' | ' | ' | ' | ' | 11,000 | ' | ' |
Secured Long-term Debt | ' | ' | ' | ' | ' | 3,028,300 | 2,190,000 | ' |
Unused credit facility | ' | ' | ' | ' | ' | 831,147 | 593,000 | ' |
Units Issued During Period, Units | 3,333,333 | ' | 1,067,774 | ' | ' | ' | ' | 2,515,000 |
Units Issued During Period, Per Unit Amount | ' | ' | ' | ' | ' | ' | ' | $1.25 |
Units Issued During Period, Value | ' | ' | $2,359,780 | ' | ' | ' | ' | $3,143,750 |
Units Issued During Period, Underlying Shares | 1 | ' | 1 | ' | ' | ' | ' | 1 |
Units Issued During Period, Underlying Warrants | 0.5 | ' | 0.5 | ' | ' | ' | ' | 0.5 |
Class of Warrant or Right, Grants in Period, Exercise Price | 0.7 | ' | $3.45 | ' | ' | ' | ' | $1.75 |
Class of Warrant or Right, Grants in Period, Contractual Term | '5 years | ' | '2 years | ' | ' | ' | ' | '2 years |
Stock Issued During Period, Finders' Fees | ' | ' | ' | ' | ' | ' | ' | 176,400 |
Schedule_of_Property_Plant_and
Schedule of Property, Plant and Equipment, Declining Balances (Details) | 12 Months Ended |
Dec. 28, 2013 | |
Automobiles [Member] | ' |
Property and Equipment, Depreciation Rate | 20.00% |
Computer equipment [Member] | ' |
Property and Equipment, Depreciation Rate | 30.00% |
Computer software [Member] | ' |
Property and Equipment, Depreciation Rate | 100.00% |
Equipment [Member] | ' |
Property and Equipment, Depreciation Rate | 30.00% |
Furniture and fixtures [Member] | ' |
Property and Equipment, Depreciation Rate | 20.00% |
Production equipment [Member] | ' |
Property and Equipment, Depreciation Rate | 30.00% |
Website development [Member] | ' |
Property and Equipment, Depreciation Rate | 100.00% |
Schedule_of_FiniteLived_Intang
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) | 12 Months Ended |
Dec. 28, 2013 | |
Patent [Member] | ' |
Finite-Lived Intangible Asset, Useful Life | '10 years |
Trademarks [Member] | ' |
Finite-Lived Intangible Asset, Useful Life | '5 years |
License Fee [Member] | ' |
Finite-Lived Intangible Asset, Useful Life | '10 years |
Schedule_of_Inventory_Current_
Schedule of Inventory, Current (Details) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Inventory, Net | $945,040 | $2,904,652 |
CRAiLAR fiber [Member] | ' | ' |
Inventory, Net | 186,464 | 0 |
Decorticated fiber [Member] | ' | ' |
Inventory, Net | 252,263 | 51,504 |
Flax seed [Member] | ' | ' |
Inventory, Net | 0 | 1,172,155 |
Raw flaw fiber feedstock [Member] | ' | ' |
Inventory, Net | 369,590 | 1,680,993 |
Others [Member] | ' | ' |
Inventory, Net | $136,723 | $0 |
Schedule_of_Inventory_Writedow
Schedule of Inventory Write-downs (Details) (USD $) | 12 Months Ended | 51 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | |
Impairment of inventory | $4,642,262 | $303,663 | $4,945,925 |
CRAiLAR fiber [Member] | ' | ' | ' |
Impairment of inventory | 274,297 | 0 | ' |
Decorticated fiber [Member] | ' | ' | ' |
Impairment of inventory | 196,861 | 0 | ' |
Flax seed [Member] | ' | ' | ' |
Impairment of inventory | 1,891,217 | 303,663 | ' |
Raw flaw fiber feedstock [Member] | ' | ' | ' |
Impairment of inventory | $2,279,887 | $0 | ' |
Property_Plant_and_Equipment_D
Property, Plant and Equipment (Details) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Property, Plant and Equipment, Gross | $18,464,408 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 1,224,396 | ' |
Property, Plant and Equipment, Net | 17,240,012 | 13,248,688 |
Automobiles [Member] | ' | ' |
Property, Plant and Equipment, Gross | 58,743 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 8,876 | ' |
Property, Plant and Equipment, Net | 49,867 | 57,559 |
Computer equipment [Member] | ' | ' |
Property, Plant and Equipment, Gross | 126,192 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 69,019 | ' |
Property, Plant and Equipment, Net | 57,180 | 48,398 |
Equipment [Member] | ' | ' |
Property, Plant and Equipment, Gross | 754,902 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 98,556 | ' |
Property, Plant and Equipment, Net | 656,346 | 359,445 |
Equipment held for sale [Member] | ' | ' |
Property, Plant and Equipment, Gross | 70,000 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 0 | ' |
Property, Plant and Equipment, Net | 70,000 | 105,045 |
Furniture and fixtures [Member] | ' | ' |
Property, Plant and Equipment, Gross | 62,339 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 36,918 | ' |
Property, Plant and Equipment, Net | 25,421 | 29,980 |
Leasehold improvements [Member] | ' | ' |
Property, Plant and Equipment, Gross | 6,327,333 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 615,459 | ' |
Property, Plant and Equipment, Net | 5,498,633 | 4,979,548 |
Production equipment [Member] | ' | ' |
Property, Plant and Equipment, Gross | 5,095,961 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 277,681 | ' |
Property, Plant and Equipment, Net | 4,818,280 | 0 |
Production equipment in construction [Member] | ' | ' |
Property, Plant and Equipment, Gross | 6,060,849 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 0 | ' |
Property, Plant and Equipment, Net | 6,060,849 | 7,606,837 |
Website development [Member] | ' | ' |
Property, Plant and Equipment, Gross | 121,330 | ' |
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | 117,365 | ' |
Property, Plant and Equipment, Net | $3,436 | $61,876 |
Schedule_of_Intangible_Assets_
Schedule of Intangible Assets and Goodwill (Details) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Finite-Lived Intangible Assets, Gross | $343,045 | ' |
Finite-Lived Intangible Assets, Accumulated Amortization | 187,500 | ' |
Finite-Lived Intangible Assets, Net | 155,545 | 94,619 |
Patent [Member] | ' | ' |
Finite-Lived Patents, Gross | 158,367 | ' |
Finite-Lived Intangible Assets, Accumulated Amortization | 72,885 | ' |
Finite-Lived Intangible Assets, Net | 85,482 | 77,961 |
Trademarks [Member] | ' | ' |
Finite-Lived Trademarks, Gross | 121,968 | ' |
Finite-Lived Intangible Assets, Accumulated Amortization | 93,903 | ' |
Finite-Lived Intangible Assets, Net | 28,065 | 7,639 |
License Fee [Member] | ' | ' |
Finite-Lived License Agreements, Gross | 62,710 | ' |
Finite-Lived Intangible Assets, Accumulated Amortization | 20,712 | ' |
Finite-Lived Intangible Assets, Net | $41,998 | $9,019 |
Schedule_of_Derivative_Instrum
Schedule of Derivative Instruments (Details) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Class of Warrant or Right, Outstanding | 6,887,580 | 3,156,848 | 3,294,229 |
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price | $1.15 | $4.02 | $3.57 |
Expiring on May 19, 2013 [Member] | ' | ' | ' |
Class of Warrant or Right, Outstanding | 275,506 | ' | ' |
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price | $1.25 | ' | ' |
Warrants and Rights Outstanding | $0 | $257,564 | ' |
Expiring on October 14, 2014 [Member] | ' | ' | ' |
Class of Warrant or Right, Outstanding | 533,887 | ' | ' |
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price | $3.45 | ' | ' |
Warrants and Rights Outstanding | 0 | 230,471 | ' |
Warrants [Member] | ' | ' | ' |
Warrants and Rights Outstanding | $0 | $488,035 | ' |
Schedule_of_Derivative_Instrum1
Schedule of Derivative Instruments, Valuation Assumptions (Details) (Warrants [Member]) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | 60.00% | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.00% | 0.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 0.09% | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | '0 years 7 months 13 days | ' |
Minimum [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | ' | 57.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | ' | 0.14% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | ' | '0 years 4 months 17 days |
Maximum [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | ' | 83.00% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | ' | 0.72% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | ' | '1 year 2 months 5 days |
Convertible_Note_Payable_Detai
Convertible Note Payable (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Principal | $669,335 | ' |
Interest | 23,781 | ' |
Repayment | -47,885 | ' |
Beneficial conversion feature | -188,140 | ' |
Accretion expense | 33,495 | ' |
Effect of foreign exchange | -13,872 | ' |
Note payable | $476,614 | $0 |
Schedule_of_Longterm_Debt_Inst
Schedule of Long-term Debt Instruments (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Long Term Debt, beginning of period | $10,051,262 | $0 |
Convertible debenture issued | 8,307,249 | 10,051,262 |
Discount on debentures | -754,829 | 0 |
Amendment of debentures conversion price | -79,931 | 0 |
Accretion expense | 94,030 | 0 |
Effect of foreign exchange | -943,095 | 0 |
Long Term Debt, end of period | $16,674,686 | $10,051,262 |
Schedule_of_Deferred_debt_issu
Schedule of Deferred debt issuance costs (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Deferred Debt Issuance Costs, beginning of period | $1,024,294 | $0 |
Issuance costs - cash | 886,733 | 1,083,936 |
Issuance costs warrants | 66,278 | 0 |
Issuance costs allocated to additional paid in capital | -102,670 | 0 |
Amortization of issuance costs | -346,789 | -59,642 |
Effect of foreign exchange | -85,823 | 0 |
Deferred Debt Issuance Costs, end of period | $1,442,023 | $1,024,294 |
Schedule_of_Stockholders_Equit
Schedule of Stockholders' Equity Note, Warrants or Rights (Details) | Dec. 28, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Class of Warrant or Right, Outstanding | 6,887,580 | 3,156,848 | 3,294,229 |
Range 1 [Member] | ' | ' | ' |
Class of Warrant or Right, Outstanding | 6,887,580 | ' | ' |
Class of Warrant or Right, Weighted Average Remaining Contractual Term | '3 years 7 months 6 days | ' | ' |
Range 1 [Member] | Minimum [Member] | ' | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights | 0.7 | ' | ' |
Range 1 [Member] | Maximum [Member] | ' | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights | 3.45 | ' | ' |
Schedule_of_Stockholders_Equit1
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Class of Warrant or Right, Outstanding, Beginning of Period | 3,156,848 | 3,294,229 |
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, Beginning of Period | $4.02 | $3.57 |
Class of Warrant or Right, Exercises in Period | -37,500 | -648,591 |
Class of Warrant or Right, Exercises in Period, Weighted Average Exercise Price | $1.25 | $1.32 |
Class of Warrant or Right, Expirations in Period | -2,585,731 | -29,957 |
Class of Warrant or Right, Expirations in Period, Weighted Average Exercise Price | $4.17 | $1.38 |
Class of Warrant or Right, Grants in Period, Net of Forfeitures | 6,353,963 | 541,167 |
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price | $0.96 | $3.42 |
Class of Warrant or Right, Outstanding, End of Period | 6,887,580 | 3,156,848 |
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, End of Period | $1.15 | $4.02 |
Schedule_of_Sharebased_Payment
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Original 2011 Fixed Share Option Plan [Member] | ' | ' |
Risk-free interest rate, Minimum | ' | 0.78% |
Risk-free interest rate, Maximum | ' | 0.92% |
Volatility factor, Minimum | ' | 88.00% |
Volatility factor, Maximum | ' | 89.00% |
Expected life of options, in years | ' | '5 years |
Weighted average fair value of options granted | ' | $2.14 |
Amended 2011 Fixed Share Option Plan [Member] | ' | ' |
Risk-free interest rate, Minimum | 0.75% | 0.18% |
Risk-free interest rate, Maximum | 0.90% | 0.39% |
Volatility factor, Minimum | 63.00% | 74.00% |
Volatility factor, Maximum | 66.00% | 75.00% |
Expected life of options, in years | '4 years 2 months 12 days | '4 years 2 months 1 day |
Weighted average fair value of options granted | $1.15 | $1.34 |
2010 Fixed Share Option Plan [Member] | ' | ' |
Risk-free interest rate, Minimum | ' | 0.90% |
Risk-free interest rate, Maximum | ' | 0.10% |
Volatility factor, Minimum | ' | 68.00% |
Volatility factor, Maximum | ' | 91.00% |
Expected life of options, in years | ' | '5 years |
Weighted average fair value of options granted | ' | $1.66 |
Schedule_of_Sharebased_Compens
Schedule of Share-based Compensation, Stock Options, Activity (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning of Period | 6,416,043 | 5,281,945 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning of Period | $1.77 | $1.48 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | 285,000 | 1,974,500 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $2.25 | $2.25 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | -196,000 | -821,229 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $0.98 | $1.06 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | -36,244 | -19,173 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | $2.09 | $1.93 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, End of Period | 6,468,799 | 6,416,043 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, End of Period | $1.81 | $1.77 |
Disclosure_of_Sharebased_Compe
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) (USD $) | 12 Months Ended | ||
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit | $0.87 | $0.87 | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit | $3.05 | $3.05 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding | 6,468,799 | 6,416,043 | 5,281,945 |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term | '2 years 5 months 16 days | '4 years 11 months 23 days | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $1.81 | $1.77 | $1.48 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | 6,301,720 | 4,304,990 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $1.81 | $1.69 | ' |
Business_Combination_Segment_A
Business Combination, Segment Allocation (Details) | 12 Months Ended | 51 Months Ended | |||
Dec. 28, 2013 | Dec. 31, 2012 | Dec. 28, 2013 | Dec. 01, 2013 | Dec. 01, 2013 | |
USD ($) | USD ($) | USD ($) | USD ($) | EUR (€) | |
Fair value of assets acquired | ' | ' | ' | $1,797,121 | ' |
Fair value of debt assumed | ' | ' | ' | -1,172,081 | -861,551 |
Deferred income tax liability | ' | ' | ' | -199,131 | ' |
Bargain purchase gain | $425,909 | $0 | $425,909 | ' | ' |
Business_Combination_Separatel
Business Combination, Separately Recognized Transactions (Details) (EUR €) | Dec. 28, 2013 |
Bank line of credit, bearing interest at 3.25%, repayable June 25, 2014 | € 313,088 |
Bank line of credit, Interest Rate | 3.25% |
Bank term loans, bearing interest ranging from 3.1% to 4.55%, repayable between September 2014 and August 2022. | 712,881 |
Bank term loans, Lower Interest Rate | 3.10% |
Bank term loans, Upper Interest Rate | 4.55% |
Loan payable on demand bearing interest at 4% per annum | 90,897 |
Loan payable on demand with interest, interest rate | 4.00% |
Loan payable on demand bearing no interest | 68,810 |
Current and Non-Current portion | 1,185,676 |
Less: current portion | 634,486 |
Non-Current portion | € 551,190 |
Schedule_of_Future_Minimum_Lea
Schedule of Future Minimum Lease Payments for Capital Leases (Details) (USD $) | Dec. 28, 2013 |
Capital Leases, Future Minimum Payments Due, Current | $296,579 |
Capital Leases, Future Minimum Payments Due in Two Years | 209,539 |
Capital Leases, Future Minimum Payments Due in Three Years | 209,539 |
Capital Leases, Future Minimum Payments Due in Four Years | 209,539 |
Capital Leases, Future Minimum Payments Due in Five Years | 209,539 |
Capital Leases, Future Minimum Payments Due | $1,134,735 |
Schedule_of_Components_of_Inco
Schedule of Components of Income Tax Expense (Benefit) (Details) (USD $) | 12 Months Ended | |
Dec. 28, 2013 | Dec. 31, 2012 | |
Loss before income taxes | $15,169,933 | $9,315,360 |
Corporate tax rate | 30.48% | 28.85% |
Expected income tax recovery | -4,623,968 | -2,654,878 |
Permanent differences and others | 255,649 | 468,899 |
Change in valuation allowance | 5,155,729 | 2,324,647 |
Impact of foreign exchange changes | -564,191 | -101,609 |
Impact of tax rate changes | -223,219 | -37,059 |
Future income tax recovery | $0 | $0 |
Schedule_of_Deferred_Tax_Asset
Schedule of Deferred Tax Assets and Liabilities (Details) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Property and equipment and intangible assets | ($168,845) | $89,513 |
Research and development costs | 999,811 | 806,068 |
Share issue costs | 165,590 | 196,805 |
Other finance costs | 1,883 | 124,546 |
Loss carry forwards | 10,999,463 | 5,824,372 |
Deferred Tax Assets, Gross | 11,997,902 | 7,041,304 |
Valuation allowance | -12,197,033 | -7,041,304 |
Deferred Tax Assets, Net, Total | ($199,131) | $0 |
Summary_of_Operating_Loss_Carr
Summary of Operating Loss Carryforwards (Details) (USD $) | Dec. 28, 2013 | Dec. 31, 2012 |
Canada [Member] | ' | ' |
Operating Loss Carryforwards | $21,672,697 | $17,964,466 |
Canada [Member] | 2014 [Member] | ' | ' |
Operating Loss Carryforwards | 992,010 | ' |
Canada [Member] | 2015 [Member] | ' | ' |
Operating Loss Carryforwards | 1,119,758 | ' |
Canada [Member] | 2026 [Member] | ' | ' |
Operating Loss Carryforwards | 1,219,361 | ' |
Canada [Member] | 2027 [Member] | ' | ' |
Operating Loss Carryforwards | 1,346,174 | ' |
Canada [Member] | 2028 [Member] | ' | ' |
Operating Loss Carryforwards | 2,160,578 | ' |
Canada [Member] | 2029 [Member] | ' | ' |
Operating Loss Carryforwards | 2,744,383 | ' |
Canada [Member] | 2030 [Member] | ' | ' |
Operating Loss Carryforwards | 1,873,136 | ' |
Canada [Member] | 2031 [Member] | ' | ' |
Operating Loss Carryforwards | 2,960,048 | ' |
Canada [Member] | 2032 [Member] | ' | ' |
Operating Loss Carryforwards | 2,443,098 | ' |
Canada [Member] | 2033 [Member] | ' | ' |
Operating Loss Carryforwards | 4,814,151 | ' |
USA [Member] | ' | ' |
Operating Loss Carryforwards | 13,507,448 | ' |
USA [Member] | 2014 [Member] | ' | ' |
Operating Loss Carryforwards | 0 | ' |
USA [Member] | 2015 [Member] | ' | ' |
Operating Loss Carryforwards | 0 | ' |
USA [Member] | 2026 [Member] | ' | ' |
Operating Loss Carryforwards | 0 | ' |
USA [Member] | 2027 [Member] | ' | ' |
Operating Loss Carryforwards | 0 | ' |
USA [Member] | 2028 [Member] | ' | ' |
Operating Loss Carryforwards | 0 | ' |
USA [Member] | 2029 [Member] | ' | ' |
Operating Loss Carryforwards | 0 | ' |
USA [Member] | 2030 [Member] | ' | ' |
Operating Loss Carryforwards | 75,478 | ' |
USA [Member] | 2031 [Member] | ' | ' |
Operating Loss Carryforwards | 594,348 | ' |
USA [Member] | 2032 [Member] | ' | ' |
Operating Loss Carryforwards | 3,476,071 | ' |
USA [Member] | 2033 [Member] | ' | ' |
Operating Loss Carryforwards | $9,361,551 | ' |